Loading
ศ. วิจิตรา ทัศนียกุล

ศ. วิจิตรา ทัศนียกุล

ภาควิชาเภสัชวิทยา,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
36949632700: H-INDEX 30
6504570838: H-INDEX 30

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Settheetham-Ishida, W
Yuenyao, P
Tassaneeyakul, W
Kanjanavirojkul, N
Thawmor, A
Kularbkaew, C
Hahvajanawong, C
Settheetham, D
Wattanathorn, J
Kashima, T
Ishida, T
0
2. Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column. Lambert, WE
de Leenheer, AP
Walgraeve, HR
Tassaneeyakul, W
1988
3. Anti-inflammatory activity of 5,7-dimethoxyflavone. Panthong, A.
Tassaneeyakul, W.
Reutrakul, V.
1989
4. A study of major causes and types of poisoning in Khonkaen, Thailand. Chirasirisap, K
Ussanawarong, S
Tassaneeyakul, W
Reungsritrakool, W
Prasitwatanaseree, W
Sripanyawit, U
Premkamol, A
Prasartthong, W
Patitas, N
1992
5. Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Tassaneeyakul, W.
McManus, M.E.
1992
6. Co-regulation of phenytoin and tolbutamide metabolism in humans. Tassaneeyakul, W.
McManus, M.E.
1992
7. High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. Tassaneeyakul, W
Veronese, ME
Birkett, DJ
Miners, JO
1993
8. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism Andersson, T
Miners, JO
Veronese, ME
Tassaneeyakul, W
Meyer, UA
Birkett, DJ
1993
9. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul, W
Birkett, DJ
Veronese, ME
McManus, ME
Tukey, RH
Quattrochi, LC
Gelboin, HV
Miners, JO
1993
10. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Tassaneeyakul, W
Veronese, ME
Birkett, DJ
Gonzalez, FJ
Miners, JO
1993
11. Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms Tassaneeyakul, W
Birkett, DJ
McManus, ME
Veronese, ME
Andersson, T
Tukey, RH
Miners, JO
1994
12. Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. Tassaneeyakul, W.
McManus, M.E.
1994
13. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. Tassaneeyakul, W
Birkett, DJ
Edwards, JW
Veronese, ME
Tukey, RH
Miners, JO
1996
14. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 Tassaneeyakul, W.
Tassaneeyakul, W.
1996
15. Limited value of the urinary phenotyoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo Tassaneeyakul, W. 1996
16. Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo. Tassaneeyakul, W
Birkett, DJ
Pass, MC
Miners, JO
1996
17. Towards Understanding Cytochromes P450 Wichittra Tassaneeyakul
Wongwiwat Tassaneeyakul
Khan Kaen Khon Kaen University
1996
18. Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents. Tassaneeyakul, W. 1998
19. Antigastric Ulcer Effect of Turmeric in Rats Patchareewan Pannangpetch
Jintanaporn Watanathorn
Orapin Phasuriwong
Wichittra Tassaneeyakul
Bunkerd Kongyingyoes
2000
20. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice Tassaneeyakul, W
Vannaprasaht, S
Yamazoe, Y
2000
21. Genetic Polymorphism of Cytochrome P450 2C19 Wichittra Tassaneeyakul
Arporn Tawalee
Wongwiwat Tassaneeyakul
2000
22. Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population Wichittra Tassaneeyakul
Arpom Tawalee
Veerapol Kukongviriyapan
Wongwiwat Tassaneeyakul
2000
23. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Tassaneeyakul, W.
Ohta, T.
Yamazoe, Y.
2000
24. Arylamine N-Acetyltransferase-2 Genotype Polymorphism in Thai Population Auemduan Prawan
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Bunkerd Kongyingyose
Thailand 40002 Khon Kaen
2001
25. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. Tassaneeyakul, W.
Tawalee, A.
Tassaneeyakul, W.
Kukongviriyapan, V.
Blaisdell, J.A.
Goldstein, J.A.
,
2002
26. Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers Wongwiwat Tassaneeyakul
Arporn Tawalee
Watchara Boonsawat
Katcharin Phunikom
Veerapol Kukongviriyapan
Prapawadee Puapairoj
Wichittra Tassaneeyakul
2002
27. Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population Somrudee Srimartpirom
Wongwiwat Tassaneeyakul
Veerapol Kukongwiriyapan
Wichittra Tassaneeyakul
2002
28. Screening for Naturally Occurring Inhibitors of Arylamine N-Acetyltransferase 1 Activity Ninatthanan Phromsopha
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Upa Kukongviriyapan
2002
29. Arylamine N-acetyltransferase-2 genotypes in the Thai population Kukongviriyapan, V
Prawan, A
Tassaneyakul, W
Aiemsa-Ard, J
Warasiha, B
2003
30. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. Tassaneeyakul, W
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphruk, A
Tassaneeyakul, W
2003
31. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003
32. Evaluation of CYP1A2 Activity in Thalassemia Patients Veerapol Kukongviriyapan
Laddawan Senggunprai
Upa Kukongviriyapan
Arunee Jetsrisuparb
Wichittra Tassaneyakul
Khon Kaen 40002 Khon Kaen University
2003
33. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population Kukongviriyapan, V
Prawan, A
Warasiha, B
Tassaneyakul, W
Aiemsa-ard, J
2003
34. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand Settheetham-Ishida, W
Singto, Y
Yuenyao, P
Tassaneeyakul, W
Kanjanavirojkul, N
Ishida, T
2004
35. Oxidative Stress and Protein Damage in Thalassemia Patients and Smokers Nuntiya Somparn
Veerapol Kukongviriyapan
Wichitra Tassaneeyakul
Upa Kukongviriyapan
KhonKaen Khon Kaen University
2004
36. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Srimartpirom, S
Tassaneeyakul, W
Kukongviriyapan, V
Tassaneeyakul, W
2004
37. Thiopurine S-methyltransferase polymorphism in the Thai population Tassaneeyakul, W.
Kukongviriyapan, V.
Tassaneeyakul, W.
2004
38. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma Prawan, A
Kukongviriyapan, V
Tassaneeyakul, W
Pairojkul, C
Bhudhisawasdi, V
2005
39. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Tepsiri, N
Chaturat, L
Sripa, B
Namwat, W
Wongkham, S
Bhudhisawasdi, V
Tassaneeyakul, W
2005
40. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients Tassaneeyakul, W
Kittiwattanagul, K
Vannaprasaht, S
Kampan, J
Tawalee, A
Puapairoj, P
Tiamkao, S
Juthagridsada, S
Kukongviriyapan, V
Tassaneeyakul, W
2005
41. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006
42. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Wichittra Tassaneeyakul
Werawath Mahatthanatrakul
Kanokporn Niwatananun
Kesara Na-Bangchang
Arporn Tawalee
Nathawut Krikreangsak
Utaiwan Cykleng
Wongwiwat Tassaneeyakul
2006
43. Effect of B-thalassemia/HbE disease on activity of cytochrome P450s Nuntiya Somparn
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Upa Kukongviriyapan
Arunee Jetsrisuparb
2006
44. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. Satarug, S.
Tassaneeyakul, W.
Na-Bangchang, K.
2006
45. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 Kukongviriyapan, V
Phromsopha, N
Tassaneeyakul, W
Kukongviriyapan, U
Sripa, B
Hahnvajanawong, V
Bhudhisawasdi, V
2006
46. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in Northeastern Thailand Settheetham-Ishida, W.
Yuenyao, P.
Tassaneeyakul, W.
Kanjanavirojkul, N.
Thawmor, A.
Kularbkaew, C.
Hahvajanawong, C.
Settheetham, D.
Wattanathorn, J.
Kashima, T.
Ishida, T.
2006
47. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Jitpimolmard, S.
Sawanyawisuth, K.
Morakote, N.
Vejjajiva, A.
Puntumetakul, M.
Sanchaisuriya, K.
Tassaneeyakul, W.
Tassaneeyakul, W.
2007
48. Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients Wichittra Tassaneeyakul
Khanogwan Kittiwattanagul
Siriporn Tiamkao
Jureeporn Kampan
Suda Vannaprasaht
Wannapa Haewdee
Prapawadee Puapairoj
Bunkerd Kongyingyoes
Wongwiwat Tassaneeyakul
2007
49. COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS Suda Vannaprasaht
Somsak Tiamkao
Aporanee Chaiyakum
Chedsada Noppawinyoowong
Detpon Preechagoon
Sirimas Kanjanawat
Wichittra Tassaneeyakul
2007
50. COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS Sirimas Kanjanawart
Suda Vannaprasaht
Panot Tangsucharit
Dhanu Gaysornsiri
Siriporn Tiamkao
Bunkerd Kongyingyoes
Roongpet Tangrassameeprasert
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2007
51. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007
52. INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Vichien Attakornvattana
Aimon Somanabandhu
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
2007
53. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients Somparn, N
Kukongviriyapan, U
Tassaneeyakul, W
Jetsrisuparb, A
Kukongviriyapan, V
2007
54. THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS Susothorn Angsuthum
Wichittra Tassaneeyakul
Cholatip Pongskul
Dhavee Sirivongs
Wongwiwat Tassaneeyakul
Yingyos Avihingsanon
Suda Vannaprasaht
2007
55. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Boonsrirat, U.
Angsuthum, S.
Vannaprasaht, S.
Kongpunvijit, J.
Hirankarn, N.
Tassaneeyakul, W.
Avihingsanon, Y.
2008
56. Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers Sirimas Kanjanawart
Bunkerd Kongyingyoes
Dhanu Gaysornsiri
Panot Tangsucharit
Prapawadee Puapairoj
Suda Vannaprasaht
Siriporn Tiamkao
Wichittra Tassaneeyakul
2008
57. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Nisana Namwat
Piyawan Amimanan
Watcharin Loilome
Patcharee Jearanaikoon
Banchob Sripa
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2008
58. Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. Tassaneeyakul, W.
Kanchanawat, S.
Gaysonsiri, D.
Vannaprasath, S.
Paupairoj, P.
Kittiwattanagul, K.
Tippabhotla, S.K.
Khuroo, A.H.
Panigrahy, B.K.
Reyar, S.
Monif, T.
2008
59. GENETIC POLYMORPHISM OF DRUG METABOLIZING ENZYMES IN THAIS Wichittra Tassaneeyakul 2008
60. Herb and Drug Interaction Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Wongwiwat Tassaneeyakul
2008
61. Monoclonal Antibody: Targeted Therapy of Cancer Sirimas Kanjanawart
Wichittra Tassaneeyakul
2008
62. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers Tangsucharit, P
Kampan, J
Kanjanawart, S
Gaysonsiri, D
Vannaprasaht, S
Tiamkao, S
Phunikhom, K
Simasathiansophon, S
Puapairoj, P
Tassaneeyakul, W
2009
63. Cadmium exposure in thai populations from central, northern and northeastern thailand and the effects of food consumption on cadmium levels Apinan, R
Satarug, S
Ruengweerayut, R
Tassaneeyakul, W
Na-Bangchang, K
2009
64. Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population Thawinee Iantararoungtong
Somsak Tiamkao
Suda Vannaprasaht
Kasemsin Pavakul
Narong Auvichayapat
Charoen Choonhakarn
Wichittra Tassaneeyakul
2009
65. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking Mahavorasirikul, W.
Tassaneeyakul, W.
Satarug, S.
Reungweerayut, R.
Na-Bangchang, C.
Na-Bangchang, K.
2009
66. Effect of Albumin on In Vitro Omeprazole Kinetics in Human Liver Microsomes Nitsupa Wattanachai
David J. Elliot
Wichittra Tassaneeyakul
John O. Miners
2009
67. Expression Profile of Genes Involved in 5-Fluorouracil Metabolic Pathway as Predictive Parameters for 5-Fluorouracil Response in Cholangiocarcinoma Jariya Chaiyagool
Chariya Hahnvajanawong
Banchob Sripa
Vajarapong Bhudhisawasdi
Narong Khuntikeo
Ake Pugkhem
Siri Chau-in
Wichittra Tassaneeyakul
2009
68. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Suda Vannaprasaht
Susothorn Angsuthum
Yingyos Avihingsanon
Dhavee Sirivongs
Cholatip Pongskul
Pattarapong Makarawate
Kearkiat Praditpornsilpa
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009
69. Influence of Genetic and Environmental Factors on Cytochrome P450-mediated Nicotine Metabolism in Thai Population Wiratchanee Mahavorasirikul
Rungnapa Apinan
Soisungwan Satarug
Wichittra Tassaneeyakul
Kesara Na-Bangchang
2009
70. Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus Theerada Taesotikul
Aimon Somanabandhu
Vichien Navinpipatana
Sirimas Kanjanawart
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009
71. Pharmacogenomics Wichittra Tassaneeyakul 2009
72. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Tassaneeyakul, W
Jantararoungtong, T
Chen, P
Lin, PY
Tiamkao, S
Khunarkornsiri, U
Chucherd, P
Konyoung, P
Vannaprasaht, S
Choonhakarn, C
Pisuttimarn, P
Sangviroon, A
Tassaneeyakul, W
2009
73. The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population Roongnapa Apinan
Wichittra Tassaneeyakul
Wiratchanee Mahavorasirikul
Soisangwang Satarug
Sirimas Kajanawart
Suda Vannaprasaht
Ronnatrai Ruenweerayut
Kesara Na-Bangchang
2009
74. Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 Wongwiwat Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Pachadaporn Chucherd
Suda Vannaprasaht
Charoen Choonhakarn
Alisara Sangviroon
Wichittra Tassaneeyakul
2010
75. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Hahnvajanawong, C.
Boonyanugomol, W.
Nasomyon, T.
Loilome, W.
Namwat, N.
Anantachoke, N.
Tassaneeyakul, W.
Sripa, B.
Namwat, W.
Reutrakul, V.
2010
76. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Wichittra Tassaneeyakul
Somsak Tiamkao
Thawinee Jantararoungtong
Pei Chen
Shu-Yi Lin
Wei-Hsuan Chen
Parinya Konyoung
Usanee Khunarkornsiri
Narong Auvichayapat
Kasemsin Pavakul
Kongkiat Kulkantrakorn
Charoen Choonhakarn
Siranun Phonhiamhan
Namfon Piyatrakul
Thiti Aungaree
Sunsanee Pongpakdee
Praphan Yodnopaglaw
2010
77. Association of HLA-B*1502 and severe cutaneous adverse reactions caused by aromatic antiepileptic drugs Wichittra Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Shu-Yi Lin
Wei-Hsuan Chen
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Alisara Sangviroon
Patcharee Kanjanawat
Arkhom Arayawhichanont
Charoen Choonhakarn
Kongkiat Kulkantrakorn
2010
78. Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers Sirimas Kanjanawart
Sontaya Simasathiansopon
Prapawadee Paupairoj
Suda Vannaprasath
Siriporn Tiamkao
Dhanu Gaysonsiri
Panot Tangsucharit
Thanawat Kaewkamson
Wichittra Tassaneeyakul
2010
79. Carbamazepine- but not Phenytoin-induced Severe Cutaneous Adverse Drug Reactions are Associated with HLA-B*1502 in a Thai Population Napat Prabmeechai
Somsak Tiamkao
Thawinee Jantararoungtong
Pansu Chumworathayi
Piyameth Dilokthornsakul
Wichittra Tassaneeyakul
2010
80. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration Tassaneeyakul, W
Kumar, S
Gaysonsiri, D
Kaewkamson, T
Khuroo, A
Tangsucharit, P
Phunikhom, K
Vannaprasaht, S
Kanjanawart, S
Rao Thudi, N
Jain, R
Reyar, S
Monif, T
2010
81. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010
82. Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data Nitsupa Wattanachai
David J. Elliot
Verawan Uchaipichat
Wichittra Tassaneeyakul
John O. Miners
2010
83. OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING John Ray
Gillian Campbell
Tony Richardson
Gill Erickson
Vaughan Carr
Peter Rofe
Wichittra Tassaneeyakul
Gary Graham
2010
84. Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin. Tassaneeyakul, W.
Namchaisiri, J.
2010
85. Selective Inhibition of Human Cytochrome P450 1A2 by Moringa oleifera Theerada Taesotikul
Vichien Navinpipatana
Wichittra Tassaneeyakul
2010
86. The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation Nitsupa Wattanachai
Wichittra Tassaneeyakul
Verawan Uchaipichat
John O. Miners
2010
87. Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme Feng, Q.
Vannaprasaht, S.
Angsuthum, S.
Avihingsanon, Y.
Tassaneeyakul, W.
2010
88. Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers. Kanjanawart, S.
Gaysonsiri, D.
Tangsucharit, P.
Vannaprasaht, S.
Phunikhom, K.
Kaewkamson, T.
Wattanachai, N.
Tassaneeyakul, W.
2011
89. Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines Chariya Hahnvajanawong
Vajarabhongsa Bhudisawadi
Nisana Namwat
Banchob Sripa
Wichittra Tassaneeyakul
2011
90. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011
91. HLA genetic polymorphism and severe cutaneous adverse drug reactions in a Thai population Wichittra Tassaneeyakul 2011
92. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Chariya Hahnvajanawong
Supaluk Ketnimit
Wongwarut Boonyanugomol
Kovit Pattanapanyasat
Yaovalux Chamgramol
Banchob Sripa
Nisana Namwat
Khosit Pinmai
Wichittra Tassaneeyakul
Vichai Reutakul
2011
93. Inhibition of human CYP1A2 activity by Thai medicinal plants with promising activities against cholangiocarcinoma Wiratchanee Mahavorasirikul
Vithoon Viyanant
Wichittra Tassaneeyakul
Kesara Na-Bangchang
2011
94. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Theerada Taesotikul
Weeraya Dumrongsakulchai
Nitsupa Wattanachai
Vichien Navinpipat
Aimon Somanabandhu
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2011
95. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Nitsupa Wattanachai
Thomas M. Polasek
Tahlia M. Heath
Verawan Uchaipichat
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
John O. Miners
2011
96. Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. Nitsupa Wattanachai
Wichittra Tassaneeyakul
Andrew Rowland
David J. Elliot
Kushari Bowalgaha
Kathleen M. Knights
John O. Miners
2012
97. Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats. Theerada Taesotikul
Miki Nakajima
Wichittra Tassaneeyakul
Tsuyoshi Yokoi
2012
98. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit, P.
Phanomsri, E.
Namwat, N.
Kampan, J.
Tassaneeyakul, W.
Loilome, W.
Puapairoj, A.
Khuntikeo, N.
2012
99. High Expression of ABCC1 Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma Umaporn Srimunta
Kanlayanee Sawanyawisuth
Ratthaphol Kraiklang
Chawalit Pairojkul
Anucha Puapairoj
Tanin Titipungul
Chariya Hahnvajanawong
Wichittra Tassaneeyakul
Chaisiri Wongkham
Sopit Wongkham
Kulthida Vaeteewoottacharn
2012
100. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Kongkiat Kulkantrakorn
Wichittra Tassaneeyakul
Somsak Tiamkao
Thawinee Jantararoungtong
Napat Prabmechai
Suda Vannaprasaht
Pansu Chumworathayi
Pei Chen
Paskorn Sritipsukho
2012
101. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Chariya Hahnvajanawong
Jariya Chaiyagool
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Nisana Namwat
Narong Khuntikeo
Banchob Sripa
Ake Pugkhem
Wichittra Tassaneeyakul
2012
102. Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. Loilome, W.
Juntana, S.
Pinitsoontorn, C.
Namwat, N.
Tassaneeyakul, W.
Yongvanit, P.
2012
103. The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients Pattarapong Makarawate
Narumol Chaosuwannakit
Suda Vannaprasaht
Koo Seok Hwee
Edmund Jon Deoon Lee
Wichittra Tassaneeyakul
2012
104. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Callaghan, J.T.
Tassaneeyakul, W.
Lee, M.T.M.
2013
105. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers. Kanjanawart, S.
Gaysonsiri, D.
Phunikom, K.
Tangsucharit, P.
Vannaprasaht, S.
Kaewkamson, T.
Tassaneeyakul, W.
2013
106. Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy. Auvichayapat, N
Rotenberg, A
Gersner, R
Ngodklang, S
Tiamkao, S
Tassaneeyakul, W
Auvichayapat, P
2013
107. Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation Vannaprasaht, S
Reungjui, S
Supanya, D
Sirivongs, D
Pongskul, C
Avihingsanon, Y
Tassaneeyakul, W
2013
108. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Chaiyakunapruk, N.
Tassaneeyakul, W.
2013
109. Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions Thachanan Kongpan
Usanee Khunakornsiri
Prarinya Konyoung
Pansu Chumworathayi
Napat Pabmeechai
Sirimas Kanjanawart
Wichittra Tassaneeyakul
2013
110. Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy Narong Auvichayapat
Alexander Rotenberg
Roman Gersner
Sudarat Ngodklang
Somsak Tiamkao
Wichittra Tassaneeyakul
Paradee Auvichayapat
2013
111. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand. Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Tassaneeyakul, W.
Sawanyawisuth, K.
2014
112. COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS S. Tiamkao
N. Nakkam
S. Kanjanawart
W. Tassaneeyakul
2014
113. Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population Tassaneeyakul, W.
Maenthaisong, R.
Chaiyakunapruk, N.
2014
114. Determination of Melatonin in Plasma by Liquid-liquid Extraction and High Performance Liquid Chromatography Coupled with Fluorescence Detection and Its Application for Melatonin Pharmacokinetic Study in Humans Nuttawut Jenjirattithigarn
Katcharin Phunikom
Thachanan Kongpan
Sirimas Kanjanawart
Jeffrey Roy Johns
Wichittra Tassaneeyakul
2014
115. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014
116. HLA-B*58:01 Genotype is Associated With Risk of Severe Cutaneous Reactions Induced by Allopurinol in Patients Admitted in Udonthani Hospital Usanee Khunakornsiri
Prarinya Konyoung
Thachanan Kongpan
Supanida Kwangsukstid
Sirimas Kanjanawart
Wichittra Tassaneeyakul
2014
117. Incidence of Drug induced-Acute Generalized Exanthematous Pustulosis (AGEP) Reported in Udonthani Hospital Prarinya Konyoung
Wichittra Tassaneeyakul
2014
118. Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Tassaneeyakul, W.
Sawanyawisuth, K.
2014
119. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014
120. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges opportunities and clinical implementation Puangpetch, A.
Tassaneeyakul, W.
2014
121. Pharmacology and Factors Affecting the Therapeutic Efficacy of Clopidogrel Nontaya Nakkam
Sirimas Kanjanawart
Somsak Tiamkao
Wichittra Tassaneeyakul
2014
122. Pharmacology and Factors Affecting the Therapeutic Efficacy of Elopidogrel Nontaya Nakkam
Sirimas Kanjanawart
Somsak Tiamkao
Wichittra Tassaneeyakul
2014
123. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions Kongpan, T
Mahasirimongkol, S
Konyoung, P
Kanjanawart, S
Chumworathayi, P
Wichukchinda, N
Kidkeukarun, R
Preechakul, S
Khunarkornsiri, U
Bamrungram, W
Supharatwattanakun, B
Mootsikapun, P
Kwangsukstid, S
Denjanta, S
Vannaprasaht, S
Rungapiromnan, W
Suwankesawong, W
Tassaneeyakul, W
Tassaneeyakul, W
2015
124. Different Enzyme Cocktail Conditions Successfully Establish Primary Brain Tumor Cell Line Derived from Pilomyxoid Astrocytoma Patient Wiyada Punjaruk
Nitsa Pasasuk
Amnat Kitkhuandee
Paradee Auvichayapat
Wichittra Tassaneeyakul
2015
125. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015
126. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Wichittra Tassaneeyakul
Napat Prabmeechai
Chonlaphat Sukasem
Thachanan Kongpan
Parinya Konyoung
Pansu Chumworathayi
Somsak Tiamkao
Usanee Khunarkornsiri
Kongkiat Kulkantrakorn
Niwat Saksit
Nontaya Nakkam
Patompong Satapornpong
Suda Vannaprasaht
Alisara Sangviroon
Surakameth Mahasirimongkol
Nuanjun Wichukchinda
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2016
127. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update Saito, Y
Stamp, LK
Caudle, KE
Hershfield, MS
McDonagh, EM
Callaghan, JT
Tassaneeyakul, W
Mushiroda, T
Kamatani, N
Goldspiel, BR
Phillips, EJ
Klein, TE
Lee, M
2016
128. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network Callaghan, J.T.
Tassaneeyakul, W.
Lee, M.T.M.
2016
129. Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication Uaepong Limpapanasit
Pisaln Mairiang
Kitti Chunlertlith
Wattana Sukeepaisarnjaroen
Suda Vannaprasaht
Wichittra Tassaneeyakul
Apichat Sangchan
Kookwan Sawadpanich
Tanita Suttichaimongkol
2016
130. The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy Duanggamon Muengsaen
Suda Vannaprasaht
Wichittra Tassaneeyakul
Kritiya Butthongkomvong
Thipawan Bowornkitiwong
Luangyot Thongthieang
Parichart Pongthai
Kosin Wirasorn
Aumkhae Sookprasert
2016
131. Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population Koomdee, N
Pratoomwun, J
Jantararoungtong, T
Theeramoke, V
Tassaneeyakul, W
Klaewsongkram, J
Rerkpattanapipat, T
Santon, S
Puangpetch, A
Intusoma, U
Tempark, T
Deesudchit, T
Satapornpong, P
Visudtibhan, A
Sukasem, C
2017
132. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Tassaneeyakul, W.
Nakkam, N.
Tiamkao, S.
Kanjanawart, S.
Phunikhom, K.
Tiamkao, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2017
133. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
. Nakkam, N
Tiamkao, S
Kanjanawart, S
Phunikhom, K
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2017
134. Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions Nakkam, N
Chumworathayi, P.
Kanjanawart, S.
Tassaneeyakul, W.
2017
135. CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION Wichittra Tassaneeyakul
Parinya Konyoung
Thachanan Kongpan
Pansu Chumworathayi
Nontaya Nakkam
Suda Vannaprasaht
Somsak Tiamkao
Chonlaphat Sukasem
Patompong Satapornpong
Wongwiwat Tassaneeyakul
2017
136. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. Therdpong Tempark
Patompong Satapornpong
Pawinee Rerknimitr
Nontaya Nakkam
Niwat Saksit
Penpun Wattanakrai
Thawinee Jantararoungtong
Napatrupron Koomdee
Ajanee Mahakkanukrauh
Wichittra Tassaneeyakul
Sumitra Suttisai
Jirawat Pratoomwun
Jettanong Klaewsongkram
Ticha Rerkpattanapipat
Chonlaphat Sukasem
2017
137. DEVELOPMENT OF A PHARMACOGENETICS-BASED WARFARIN DOSING ALGORITHM FOR THAI PATIENTS Nitsupa Wattanachai
Sutthida Kaewmoongkun
Wichittra Tassaneeyakul
2017
138. GENETIC MARKERS FOR SEVERE CUTANEOUS ADVERSE DRUG REACTIONS IN THAI POPULATION AND THEIR CLINICAL STATUS Wichittra Tassaneeyakul 2017
139. HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI Chonlaphat Sukasem
Therdpong Tempark
Patompong Satapornpong
Pawinee Rerknimitr
Jettanong Klaewsongkram
Wichittra Tassaneeyakul
2017
140. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Namwat, N.
Yongvanit, P.
Loilome, W.
Khuntikeo, N.
Tassaneeyakul, W.
Tangsucharit, P.
Yothaisong, S.
2017
141. Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication Chunlertlith, K
Limpapanasit, U
Mairiang, P
Vannaprasaht, S
Tassaneeyakul, W
Sangchan, A
Sawadpanich, K
Suttichaimongkol, T
Pongpit, J
Pattarapongsin, M
2017
142. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians Chen, CB
Hsiao, YH
Wu, T
Hsih, MS
Tassaneeyakul, W
Jorns, TP
Sukasem, C
Hsu, CN
Su, SC
Chang, WC
Hui, RC
Chu, CY
Chen, YJ
Wu, CY
Hsu, CK
Chiu, TM
Sun, PL
Lee, HE
Yang, CY
Kao, PH
Yang, CH
Ho, HC
Lin, JY
Chang, YC
Chen, MJ
Lu, CW
Ng, CY
Kuo, KL
Lin, CY
Yang, CS
Chen, DP
Chang, PY
Wu, TL
Lin, YJ
Weng, YC
Kuo, TT
Hung, SI
Chung, WH
,
2017
143. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Niwat Saksit
Wichittra Tassaneeyakul
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Pansu Chumworathayi
Chonlaphat Sukasem
Sumitra Suttisai
Napacha Piriyachananusorn
Pawinee Tiwong
Nathorn Chaiyakunapruk
Kittisak Sawanyawisuth
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2017
144. SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Sahasthas, D.
Tassaneeyakul, W.
Sawanyawisuth, K.I.
2017
145. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. Nitsupa Wattanachai
Sutthida Kaewmoongkun
Burabha Pussadhamma
Pattarapong Makarawate
Chaiyasith Wongvipaporn
Songsak Kiatchoosakun
Suda Vannaprasaht
Wichittra Tassaneeyakul
2017
146. Cost-effectiveness analysis of HLA-B ∗ 58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population Huey Yi Chong
Yi Heng Lim
Juthamas Prawjaeng
Wichittra Tassaneeyakul
Zahurin Mohamed
Nathorn Chaiyakunapruk
2018
147. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminai neuralgia Chutikorn Khuankaew
Nattayaporn Apaijai
Passakorn Sawaddiruk
Thidarat Jaiwongkann
Sasiwan Kerdphoo
Surawut Pongsiriwet
Wichittra Tassaneeyakul
Nipon Chattipakorn
Siriporn C. Chattipakorn
2018
148. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia. Tassaneeyakul, W. 2018
149. HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population Nontaya Nakkam
Parinya Konyoung
Sirimas Kanjanawart
Niwat Saksit
Thachanan Kongpan
Kanyarat Khaeso
Usanee Khunarkornsiri
Areerat Domsena
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2018
150. New Advances in Drug Hypersensitivity Research and Treatment. Yi-Giien Tsai
Wen-Hung Chung
Riichiro Abe
Wichittra Tassaneeyakul
2018
151. Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. Nakkam, N
Konyoung, P
Kanjanawart, S
Saksit, N
Kongpan, T
Khaeso, K
Khunarkornsiri, U
Dornsena, A
Tassaneeyakul, W
Tassaneeyakul, W
2018
152. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians Su, SC
Chen, CB
Chang, WC
Wang, CW
Fan, WL
Lu, LY
Nakamura, R
Saito, Y
Ueta, M
Kinoshita, S
Sukasem, C
Yampayon, K
Kijsanayotin, P
Nakkam, N
Saksit, N
Tassaneeyakul, W
Aihara, M
Lin, YJ
Chang, CJ
Wu, T
Hung, SI
Chung, WH
2019
153. Identification of drug-specific public TCR driving severe cutaneous adverse reactions Pan, RY
Chu, MT
Wang, CW
Lee, YS
Lemonnier, F
Michels, AW
Schutte, R
Ostrov, DA
Chen, CB
Phillips, EJ
Mallal, SA
Mockenhaupt, M
Bellón, T
Tassaneeyakul, W
White, KD
Roujeau, JC
Chung, WH
Hung, SI
2019
154. Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect Leong, SL
Chaiyakunapruk, N
Tassaneeyakul, W
Arunmanakul, P
Nathisuwan, S
Lee, SWH
2019
155. The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label Wang, YH
Chen, CB
Tassaneeyakul, W
Saito, Y
Aihara, M
Choon, SE
Lee, HY
Chang, MM
Roa, FD
Wu, CW
Zhang, J
Nakkam, N
Konyoung, P
Okamoto-Uchida, Y
Cheung, CM
Huang, JW
Ji, C
Cheng, B
Hui, RC
Chu, CY
Chen, YJ
Wu, CY
Hsu, CK
Chiu, TM
Huang, YH
Lu, CW
Yang, CY
Lin, YT
Chi, MH
Ho, HC
Lin, JY
Yang, CH
Chang, YC
Su, SC
Wang, CW
Fan, WL
Hung, SI
Chung, WH
,
2019
Count 79 86 81 30

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Anti-inflammatory activity of 5,7-dimethoxyflavone Panthong, A.
Tassaneeyakul, W.
Reutrakul, V.
1989 Planta Medica
2 (55), pp. 133-136
2. Caffeine as a probe for human cytochromes p450: Validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques Tassaneeyakul, W.
McManus, M.E.
1992 Pharmacogenetics
4 (2), pp. 173-183
3. Co-regulation of phenytoin and tolbutamide metabolism in humans Tassaneeyakul, W.
McManus, M.E.
1992 British Journal of Clinical Pharmacology
6 (34), pp. 494-498
4. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism Tassaneeyakul, W.
Tassaneeyakul, W.
1993 British Journal of Clinical Pharmacology
6 (36), pp. 521-530
5. Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms Tassaneeyakul, W.
McManus, M.E.
Tassaneeyakul, W.
1994 Biochemical Pharmacology
10 (47), pp. 1767-1776
6. Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2 Tassaneeyakul, W.
McManus, M.E.
1994 Pharmacogenetics
5 (4), pp. 281-284
7. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 Tassaneeyakul, W.
Tassaneeyakul, W.
1996 Journal of Pharmacology and Experimental Therapeutics
1 (276), pp. 101-108
8. Limited value of the urinary phenotyoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo Tassaneeyakul, W. 1996 British Journal of Clinical Pharmacology
6 (42), pp. 774-778
9. Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and nonsteroidal anti-inflammatory agents Tassaneeyakul, W. 1998 Xenobiotica
3 (28), pp. 293-301
10. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice Tassaneeyakul, W.
Tassaneeyakul, W.
Vannaprasaht, S.
Yamazoe, Y.
2000 British Journal of Clinical Pharmacology
2 (49), pp. 139-144
11. Inhibition selectivity of grapefruit juice components on human cytochromes P450 Tassaneeyakul, W.
Ohta, T.
Yamazoe, Y.
2000 Archives of Biochemistry and Biophysics
2 (378), pp. 356-363
12. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population Tassaneeyakul, W.
Tawalee, A.
Tassaneeyakul, W.
Kukongviriyapan, V.
Blaisdell, J.A.
Goldstein, J.A.
,
2002 Pharmacogenetics
3 (12), pp. 221-225
13. Arylamine N-acetyltransferase-2 genotypes in the Thai population Kukongviriyapan, V.
Prawan, A.
Tassaneyakul, W.
Aiemsa-ard, J.
Cushnie, B.
2003 British Journal of Clinical Pharmacology
3 (55), pp. 278-281
14. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003 Transplantation
1 (76), pp. 265-266
15. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population Kukongviriyapan, V.
Prawan, A.
Cushnie, B.
Tassaneyakul, W.
Aiemsa-ard, J.
2003 European Journal of Clinical Pharmacology
4 (59), pp. 277-281
16. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand Settheetham-Ishida, W.
Singto, Y.
Yuenyao, P.
Tassaneeyakul, W.
Kanjanavirojkul, N.
Ishida, T.
2004 Cancer Letters
2 (210), pp. 205-211
17. Thiopurine S-methyltransferase polymorphism in the Thai population Tassaneeyakul, W.
Kukongviriyapan, V.
Tassaneeyakul, W.
2004 British Journal of Clinical Pharmacology
1 (58), pp. 66-70
18. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma Prawan, A.
Kukongviriyapan, V.
Tassaneeyakul, W.
Pairojkul, C.
Bhudhisawasdi, V.
2005 European Journal of Cancer Prevention
3 (14), pp. 245-250
19. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Tepsiri, N.N.
Chaturat, L.
Sripa, B.
Namwat, W.
Wongkham, S.
Bhudhisawasdi, V.
Tassaneeyakul, W.
2005 World Journal of Gastroenterology
18 (11), pp. 2748-2753
20. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients Tassaneeyakul, W.
Kittiwattanagul, K.
Vannaprasaht, S.
Kampan, J.
Tawalee, A.
Puapairoj, P.
Taimkao, S.
Kukongviriyapan, V.
Tassaneeyakul, W.
2005 Journal of Pharmacy and Pharmaceutical Sciences
1 (8), pp. 47-53
21. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Tassaneeyakul, W.
Mahatthanatrakul, W.
Niwatananun, K.
Na-Bangchang, K.
Tawalee, A.
Krikreangsak, N.
Cykleng, U.
Tassaneeyakul, W.
2006 Drug metabolism and pharmacokinetics
4 (21), pp. 286-290
22. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. Satarug, S.
Tassaneeyakul, W.
Na-Bangchang, K.
2006 Current clinical pharmacology
3 (1), pp. 291-309
23. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 Kukongviriyapan, V.
Phromsopha, N.
Tassaneeyakul, W.
Kukongviriyapan, U.
Sripa, B.
Hahnvajanawong, V.
Bhudhisawasdi, V.
2006 Xenobiotica
1 (36), pp. 15-28
24. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in Northeastern Thailand Settheetham-Ishida, W.
Yuenyao, P.
Tassaneeyakul, W.
Kanjanavirojkul, N.
Thawmor, A.
Kularbkaew, C.
Hahvajanawong, C.
Settheetham, D.
Wattanathorn, J.
Kashima, T.
Ishida, T.
2006 Asian Pacific Journal of Cancer Prevention
1 (7), pp. 113-118
25. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Jitpimolmard, S.
Sawanyawisuth, K.
Morakote, N.
Vejjajiva, A.
Puntumetakul, M.
Sanchaisuriya, K.
Tassaneeyakul, W.
Tassaneeyakul, W.
2007 Parasitology Research
6 (100), pp. 1293-1296
26. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients Somparn, N.
Kukongviriyapan, U.
Tassaneeyakul, W.
Jetsrisuparb, A.
Kukongviriyapan, V.
2007 European Journal of Clinical Pharmacology
1 (63), pp. 43-50
27. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism Boonsrirat, U.
Angsuthum, S.
Vannaprasaht, S.
Kongpunvijit, J.
Hirankarn, N.
Tassaneeyakul, W.
Avihingsanon, Y.
2008 Lupus
2 (17), pp. 132-134
28. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Namwat, N.
Amimanan, P.
Loilome, W.
Jearanaikoon, P.
Sripa, B.
Bhudhisawasdi, V.
Tassaneeyakul, W.
2008 Chemotherapy
5 (54), pp. 343-351
29. Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers Tassaneeyakul, W.
Kanchanawat, S.
Gaysonsiri, D.
Vannaprasath, S.
Paupairoj, P.
Kittiwattanagul, K.
Tippabhotla, S.K.
Khuroo, A.H.
Panigrahy, B.K.
Reyar, S.
Monif, T.
2008 International Journal of Clinical Pharmacology and Therapeutics
3 (46), pp. 151-156
30. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers Tangsucharit, P.
Kampan, J.
Kanjanawart, S.
Gaysonsiri, D.
Vannaprasaht, S.
Tiamkao, S.
Phunikhom, K.
Simasathiansophon, S.
Puapairoj, P.
Tassaneeyakul, W.
2009 International Journal of Clinical Pharmacology and Therapeutics
10 (47), pp. 638-642
31. Cadmium exposure in thai populations from central, northern and northeastern thailand and the effects of food consumption on cadmium levels Apinan, R.
Satarug, S.
Tassaneeyakul, W.
Na-Bangchang, K.
2009 Southeast Asian Journal of Tropical Medicine and Public Health
1 (40), pp. 177-186
32. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking Mahavorasirikul, W.
Tassaneeyakul, W.
Satarug, S.
Reungweerayut, R.
Na-Bangchang, C.
Na-Bangchang, K.
2009 European Journal of Clinical Pharmacology
4 (65), pp. 377-384
33. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand Vannaprasaht, S.
Angsuthum, S.
Avihingsanon, Y.
Sirivongs, D.
Pongskul, C.
Makarawate, P.
Tassaneeyakul, W.
Tassaneeyakul, W.
2009 Clinical Therapeutics
7 (31), pp. 1524-1533
34. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Tassaneeyakul, W.
Jantararoungtong, T.
Tiamkao, S.
Vannaprasaht, S.
Choonhakarn, C.
Pisuttimarn, P.
Tassaneeyakul, W.
2009 Pharmacogenetics and Genomics
9 (19), pp. 704-709
35. The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population Apinan, R.
Tassaneeyakul, W.
Mahavorasirikul, W.
Satarug, S.
Vannaprasaht, S.
Ruenweerayut, R.
Na-Bangchang, K.
2009 Environmental Toxicology and Pharmacology
3 (28), pp. 420-424
36. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Hahnvajanawong, C.
Boonyanugomol, W.
Nasomyon, T.
Loilome, W.
Namwat, N.
Anantachoke, N.
Tassaneeyakul, W.
Sripa, B.
Namwat, W.
Reutrakul, V.
2010 World Journal of Gastroenterology
18 (16), pp. 2235-2243
37. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Tassaneeyakul, W.
Tiamkao, S.
Jantararoungtong, T.
Auvichayapat, N.
Pavakul, K.
Choonhakarn, C.
Phonhiamhan, S.
Piyatrakul, N.
Aungaree, T.
Pongpakdee, S.
Yodnopaglaw, P.
2010 Epilepsia
5 (51), pp. 926-930
38. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration Tassaneeyakul, W.
Kumar, S.M.
Gaysonsiri, D.
Kaewkamson, T.
Khuroo, A.H.
Tangsucharit, P.
Phunikhom, K.
Vannaprasaht, S.
Kanjanawart, S.
Rao Thudi, N.
Jain, R.K.
Reyar, S.
Monif, T.
2010 International Journal of Clinical Pharmacology and Therapeutics
9 (48), pp. 614-620
39. Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin Tassaneeyakul, W.
Namchaisiri, J.
2010 Drug Metabolism and Pharmacokinetics
6 (25), pp. 531-538
40. Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme Feng, Q.
Vannaprasaht, S.
Angsuthum, S.
Avihingsanon, Y.
Tassaneeyakul, W.
2010 Biochemical Pharmacology
7 (79), pp. 1053-1061
41. Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers Kanjanawart, S.
Gaysonsiri, D.
Tangsucharit, P.
Vannaprasaht, S.
Phunikhom, K.
Kaewkamson, T.
Wattanachai, N.
Tassaneeyakul, W.
2011 International Journal of Clinical Pharmacology and Therapeutics
8 (49), pp. 525-530
42. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases Namwat, N.
Puetkasichonpasutha, J.
Loilome, W.
Yongvanit, P.
Techasen, A.
Puapairoj, A.
Sripa, B.
Tassaneeyakul, W.
Khuntikeo, N.
Wongkham, S.
2011 Journal of Gastroenterology
5 (46), pp. 664-675
43. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Hahnvajanawong, C.
Ketnimit, S.
Boonyanugomol, W.
Chamgramol, Y.
Sripa, B.
Namwat, N.
Pinmai, K.
Tassaneeyakul, W.
Reutrakul, V.
2011 Asian Biomedicine
6 (5), pp. 775-785
44. Inhibitory effects of phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: Evidence for CYP3A4 mechanism-based Inhibition Taesotikul, T.
Dumrongsakulchai, W.
Wattanachai, N.
Tassaneeyakul, W.
Tassaneeyakul, W.
2011 Drug Metabolism and Pharmacokinetics
2 (26), pp. 154-161
45. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Wattanachai, N.
Uchaipichat, V.
Tassaneeyakul, W.
Tassaneeyakul, W.
2011 European Journal of Clinical Pharmacology
8 (67), pp. 815-824
46. Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: Impact on in vitro-in vivo extrapolation of drug clearance Wattanachai, N.
Tassaneeyakul, W.
2012 Drug Metabolism and Disposition
5 (40), pp. 982-989
47. Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats Taesotikul, T.
Tassaneeyakul, W.
2012 Xenobiotica
7 (42), pp. 641-648
48. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Yongvanit, P.
Phanomsri, E.
Namwat, N.
Kampan, J.
Tassaneeyakul, W.
Loilome, W.
Puapairoj, A.
Khuntikeo, N.
2012 Parasitology International
1 (61), pp. 162-166
49. High Expression of ABCC1 Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma Srimunta, U.
Sawanyawisuth, K.
Kraiklang, R.
Pairojkul, C.
Puapairoj, A.
Titipungul, T.
Hahnvajanawong, C.
Tassaneeyakul, W.
Wongkham, C.
Wongkham, S.
Vaeteewoottacharn, K.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 125-130
50. HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain Tassaneeyakul, W.
Tiamkao, S.
Jantararoungtong, T.
Prabmechai, N.
Vannaprasaht, S.
Chumworathayi, P.
2012 Pain Practice
3 (12), pp. 202-208
51. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Hahnvajanawong, C.
Chaiyagool, J.
Seubwai, W.
Bhudhisawasdi, V.
Namwat, N.
Khuntikeo, N.
Sripa, B.
Pugkhem, A.
Tassaneeyakul, W.
2012 World Journal of Gastroenterology
30 (18), pp. 3955-3961
52. Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells Loilome, W.
Juntana, S.
Pinitsoontorn, C.
Namwat, N.
Tassaneeyakul, W.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 143-147
53. Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-b genotype and allopurinol dosing Callaghan, J.T.
Tassaneeyakul, W.
Lee, M.T.M.
2013 Clinical Pharmacology and Therapeutics
2 (93), pp. 153-158
54. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers Kanjanawart, S.
Gaysonsiri, D.
Phunikom, K.
Tangsucharit, P.
Vannaprasaht, S.
Kaewkamson, T.
Tassaneeyakul, W.
2013 International Journal of Clinical Pharmacology and Therapeutics
3 (51), pp. 249-254
55. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation Vannaprasaht, S.
Reungjui, S.
Supanya, D.
Sirivongs, D.
Pongskul, C.
Avihingsanon, Y.
Tassaneeyakul, W.
2013 Clinical Therapeutics
11 (35), pp. 1762-1769
56. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis Chaiyakunapruk, N.
Tassaneeyakul, W.
2013 JAMA Dermatology
9 (149), pp. 1025-1032
57. Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy Auvichayapat, N.
Rotenberg, A.
Gersner, R.
Ngodklang, S.
Tiamkao, S.
Tassaneeyakul, W.
Auvichayapat, P.
2013 Brain Stimulation
4 (6), pp. 696-700
58. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Tassaneeyakul, W.
Sawanyawisuth, K.
2014 Singapore Medical Journal
4 (55), pp. 217-220
59. Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population Tassaneeyakul, W.
Maenthaisong, R.
Chaiyakunapruk, N.
2014 PLoS ONE
4 (9), pp.
60. High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis Thongchot, S.
Yongvanit, P.
Loilome, W.
Seubwai, W.
Phunicom, K.
Tassaneeyakul, W.
Pairojkul, C.
Promkotra, W.
Techasen, A.
Namwat, N.
2014 Asian Pacific Journal of Cancer Prevention
14 (15), pp. 5873-5878
61. Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Tassaneeyakul, W.
Sawanyawisuth, K.
2014 Journal of Arrhythmia
1 (30), pp. 55-57
62. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jongthawin, J.
Chusorn, P.
Techasen, A.
Loilome, W.
Boonmars, T.
Thanan, R.
Puapairoj, A.
Khuntikeo, N.
Tassaneeyakul, W.
Yongvanit, P.
Namwat, N.
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-8064
63. Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation Puangpetch, A.
Tassaneeyakul, W.
2014 Asian Pacific Journal of Allergy and Immunology
2 (32), pp. 111-123
64. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions Kongpan, T.
Mahasirimongkol, S.
Kanjanawart, S.
Chumworathayi, P.
Mootsikapun, P.
Vannaprasaht, S.
Tassaneayakul, W.
Tassaneeyakul, W.
2015 Pharmacogenetics and Genomics
8 (25), pp. 402-411
65. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions Nakkam, N.
Tiamkao, S.
Kanjanawart, S.
Tiamkao, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2015 Drug Metabolism and Pharmacokinetics
4 (30), pp. 295-304
66. Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population Tassaneeyakul, W.
Kongpan, T.
Chumworathayi, P.
Tiamkao, S.
Nakkam, N.
Vannaprasaht, S.
Mahasirimongkol, S.
Tassaneeyakul, W.
2016 Pharmacogenetics and Genomics
5 (26), pp. 225-234
67. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network Callaghan, J.T.
Tassaneeyakul, W.
Lee, M.T.M.
2016 Clinical Pharmacology and Therapeutics
1 (99), pp. 36-37
68. Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population Jantararoungtong, T.
Tassaneeyakul, W.
Puangpetch, A.
2017 Frontiers in Pharmacology
NOV (8), pp.
69. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Tassaneeyakul, W.
Nakkam, N.
Tiamkao, S.
Kanjanawart, S.
Phunikhom, K.
Tiamkao, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2017 International Journal of Clinical Pharmacology and Therapeutics
2 (55), pp. 177-185
70. Comparison between the HLA-B ∗ 58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions Nakkam, N
Chumworathayi, P.
Kanjanawart, S.
Tassaneeyakul, W.
2017 Journal of Immunology Research
(2017), pp.
71. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population Nakkam, N.
Wattanakrai, P.
Jantararoungtong, T.
Mahakkanukrauh, A.
Tassaneeyakul, W.
2017 Pharmacogenetics and Genomics
12 (27), pp. 429-437
72. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Namwat, N.
Yongvanit, P.
Loilome, W.
Khuntikeo, N.
Tassaneeyakul, W.
Tangsucharit, P.
Yothaisong, S.
2017 Parasitology International
4 (66), pp. 471-478
73. Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication Mairiang, P.
Vannaprasaht, S.
Tassaneeyakul, W.
Sangchan, A.
Sawadpanich, K.
2017 Asian Pacific Journal of Cancer Prevention
4 (18), pp. 927-932
74. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians Tassaneeyakul, W.
Jorns, T.P.
2017 Neurology
1 (88), pp. 78-86
75. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population Tassaneeyakul, W.
Nakkam, N.
Chumworathayi, P.
Chaiyakunapruk, N.
Sawanyawisuth, K.I.
Tassaneeyakul, W.
2017 Pharmacogenetics and Genomics
7 (27), pp. 255-263
76. SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome Makarawate, P.
Chaosuwannakit, N.
Vannaprasaht, S.
Sahasthas, D.
Tassaneeyakul, W.
Sawanyawisuth, K.I.
2017 Journal of the American Heart Association
6 (6), pp.
77. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients Wattanachai, N.
Pussadhamma, B.
Makarawate, P.
Wongvipaporn, C.
Kiatchoosakun, S.
Vannaprasaht, S.
Tassaneeyakul, W.
2017 European Journal of Clinical Pharmacology
8 (73), pp. 973-980
78. Cost-effectiveness analysis of HLA-B ∗ 58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population Tassaneeyakul, W.
Chaiyakunapruk, N.
2018 Pharmacogenetics and Genomics
2 (28), pp. 56-67
79. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia Tassaneeyakul, W. 2018 Free Radical Research
4 (52), pp. 415-425

Title Authors Year Journal title
1. Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column. Lambert, WE
de Leenheer, AP
Walgraeve, HR
Tassaneeyakul, W
1988 Journal of chromatography
1 (427), pp. 195-8
2. Anti-inflammatory activity of 5,7-dimethoxyflavone. Panthong, A
Tassaneeyakul, W
Kanjanapothi, D
Tantiwachwuttikul, P
Reutrakul, V
1989 Planta medica
2 (55), pp. 133-6
3. Co-regulation of phenytoin and tolbutamide metabolism in humans. Tassaneeyakul, W
Veronese, ME
Birkett, DJ
Doecke, CJ
McManus, ME
Sansom, LN
Miners, JO
1992 British journal of clinical pharmacology
6 (34), pp. 494-8
4. Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Tassaneeyakul, W
Mohamed, Z
Birkett, DJ
McManus, ME
Veronese, ME
Tukey, RH
Quattrochi, LC
Gonzalez, FJ
Miners, JO
1992 Pharmacogenetics
4 (2), pp. 173-83
5. A study of major causes and types of poisoning in Khonkaen, Thailand. Chirasirisap, K
Ussanawarong, S
Tassaneeyakul, W
Reungsritrakool, W
Prasitwatanaseree, W
Sripanyawit, U
Premkamol, A
Prasartthong, W
Patitas, N
1992 Veterinary and human toxicology
6 (34), pp. 489-92
6. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Andersson, T
Miners, JO
Veronese, ME
Tassaneeyakul, W
Meyer, UA
Birkett, DJ
1993 British journal of clinical pharmacology
6 (36), pp. 521-30
7. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Tassaneeyakul, W
Veronese, ME
Birkett, DJ
Gonzalez, FJ
Miners, JO
1993 Biochemical pharmacology
11 (46), pp. 1975-81
8. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul, W
Birkett, DJ
Veronese, ME
McManus, ME
Tukey, RH
Quattrochi, LC
Gelboin, HV
Miners, JO
1993 The Journal of pharmacology and experimental therapeutics
1 (265), pp. 401-7
9. High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. Tassaneeyakul, W
Veronese, ME
Birkett, DJ
Miners, JO
1993 Journal of chromatography
1 (616), pp. 73-8
10. Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. Tassaneeyakul, W
Birkett, DJ
Veronese, ME
McManus, ME
Tukey, RH
Miners, JO
1994 Pharmacogenetics
5 (4), pp. 281-4
11. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Tassaneeyakul, W
Birkett, DJ
McManus, ME
Veronese, ME
Andersson, T
Tukey, RH
Miners, JO
1994 Biochemical pharmacology
10 (47), pp. 1767-76
12. Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. Tassaneeyakul, W
Birkett, DJ
Edwards, JW
Veronese, ME
Tukey, RH
Miners, JO
1996 The Journal of pharmacology and experimental therapeutics
1 (276), pp. 101-8
13. Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo. Tassaneeyakul, W
Birkett, DJ
Pass, MC
Miners, JO
1996 British journal of clinical pharmacology
6 (42), pp. 774-8
14. Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and non-steroidal anti-inflammatory agents. Tassaneeyakul, W
Birkett, DJ
Miners, JO
1998 Xenobiotica; the fate of foreign compounds in biological systems
3 (28), pp. 293-301
15. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Tassaneeyakul, W
Vannaprasaht, S
Yamazoe, Y
2000 British journal of clinical pharmacology
2 (49), pp. 139-44
16. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Tassaneeyakul, W
Guo, LQ
Fukuda, K
Ohta, T
Yamazoe, Y
2000 Archives of biochemistry and biophysics
2 (378), pp. 356-63
17. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. Tassaneeyakul, W
Tawalee, A
Tassaneeyakul, W
Kukongviriyapan, V
Blaisdell, J
Goldstein, JA
Gaysornsiri, D
2002 Pharmacogenetics
3 (12), pp. 221-5
18. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. Tassaneeyakul, W
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphruk, A
Tassaneeyakul, W
2003 Transplantation
1 (76), pp. 265-6
19. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population. Kukongviriyapan, V
Prawan, A
Warasiha, B
Tassaneyakul, W
Aiemsa-ard, J
2003 European journal of clinical pharmacology
4 (59), pp. 277-81
20. Arylamine N-acetyltransferase-2 genotypes in the Thai population. Kukongviriyapan, V
Prawan, A
Tassaneyakul, W
Aiemsa-Ard, J
Warasiha, B
2003 British journal of clinical pharmacology
3 (55), pp. 278-81
21. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Srimartpirom, S
Tassaneeyakul, W
Kukongviriyapan, V
Tassaneeyakul, W
2004 British journal of clinical pharmacology
1 (58), pp. 66-70
22. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. Settheetham-Ishida, W
Singto, Y
Yuenyao, P
Tassaneeyakul, W
Kanjanavirojkul, N
Ishida, T
2004 Cancer letters
2 (210), pp. 205-11
23. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. Tepsiri, N
Chaturat, L
Sripa, B
Namwat, W
Wongkham, S
Bhudhisawasdi, V
Tassaneeyakul, W
2005 World journal of gastroenterology : WJG
18 (11), pp. 2748-53
24. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. Prawan, A
Kukongviriyapan, V
Tassaneeyakul, W
Pairojkul, C
Bhudhisawasdi, V
2005 European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
3 (14), pp. 245-50
25. Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. Tassaneeyakul, W
Kittiwattanagul, K
Vannaprasaht, S
Kampan, J
Tawalee, A
Puapairoj, P
Tiamkao, S
Juthagridsada, S
Kukongviriyapan, V
Tassaneeyakul, W
2005 Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques
1 (8), pp. 47-53
26. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2. Kukongviriyapan, V
Phromsopha, N
Tassaneeyakul, W
Kukongviriyapan, U
Sripa, B
Hahnvajanawong, V
Bhudhisawasdi, V
2006 Xenobiotica; the fate of foreign compounds in biological systems
1 (36), pp. 15-28
27. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Tassaneeyakul, W
Mahatthanatrakul, W
Niwatananun, K
Na-Bangchang, K
Tawalee, A
Krikreangsak, N
Cykleng, U
Tassaneeyakul, W
2006 Drug metabolism and pharmacokinetics
4 (21), pp. 286-90
28. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. Satarug, S
Tassaneeyakul, W
Na-Bangchang, K
Cashman, JR
Moore, MR
2006 Current clinical pharmacology
3 (1), pp. 291-309
29. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. Jitpimolmard, S
Sawanyawisuth, K
Morakote, N
Vejjajiva, A
Puntumetakul, M
Sanchaisuriya, K
Tassaneeyakul, W
Tassaneeyakul, W
Korwanich, N
2007 Parasitology research
6 (100), pp. 1293-6
30. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Somparn, N
Kukongviriyapan, U
Tassaneeyakul, W
Jetsrisuparb, A
Kukongviriyapan, V
2007 European journal of clinical pharmacology
1 (63), pp. 43-50
31. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Boonsrirat, U
Angsuthum, S
Vannaprasaht, S
Kongpunvijit, J
Hirankarn, N
Tassaneeyakul, W
Avihingsanon, Y
2008 Lupus
2 (17), pp. 132-4
32. Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. Tassaneeyakul, W
Kanchanawat, S
Gaysonsiri, D
Vannaprasath, S
Paupairoj, P
Kittiwattanagul, K
Tippabhotla, SK
Khuroo, A
Panigrahy, BK
Reyar, S
Monif, T
2008 International journal of clinical pharmacology and therapeutics
3 (46), pp. 151-6
33. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. Namwat, N
Amimanan, P
Loilome, W
Jearanaikoon, P
Sripa, B
Bhudhisawasdi, V
Tassaneeyakul, W
2008 Chemotherapy
5 (54), pp. 343-51
34. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers. Tangsucharit, P
Kampan, J
Kanjanawart, S
Gaysonsiri, D
Vannaprasaht, S
Tiamkao, S
Phunikhom, K
Simasathiansophon, S
Puapairoj, P
Tassaneeyakul, W
2009 International journal of clinical pharmacology and therapeutics
10 (47), pp. 638-42
35. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul, W
Jantararoungtong, T
Chen, P
Lin, PY
Tiamkao, S
Khunarkornsiri, U
Chucherd, P
Konyoung, P
Vannaprasaht, S
Choonhakarn, C
Pisuttimarn, P
Sangviroon, A
Tassaneeyakul, W
2009 Pharmacogenetics and genomics
9 (19), pp. 704-9
36. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Vannaprasaht, S
Angsuthum, S
Avihingsanon, Y
Sirivongs, D
Pongskul, C
Makarawate, P
Praditpornsilpa, K
Tassaneeyakul, W
Tassaneeyakul, W
2009 Clinical therapeutics
7 (31), pp. 1524-33
37. The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population. Apinan, R
Tassaneeyakul, W
Mahavorasirikul, W
Satarug, S
Kajanawart, S
Vannaprasaht, S
Ruenweerayut, R
Na-Bangchang, K
2009 Environmental toxicology and pharmacology
3 (28), pp. 420-4
38. Cadmium exposure in Thai populations from central, northern and northeastern Thailand and the effects of food consumption on cadmium levels. Apinan, R
Satarug, S
Ruengweerayut, R
Tassaneeyakul, W
Na-Bangchang, K
2009 The Southeast Asian journal of tropical medicine and public health
1 (40), pp. 177-86
39. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking. Mahavorasirikul, W
Tassaneeyakul, W
Satarug, S
Reungweerayut, R
Na-Bangchang, C
Na-Bangchang, K
2009 European journal of clinical pharmacology
4 (65), pp. 377-84
40. Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration. Tassaneeyakul, W
Kumar, S
Gaysonsiri, D
Kaewkamson, T
Khuroo, A
Tangsucharit, P
Phunikhom, K
Vannaprasaht, S
Kanjanawart, S
Rao Thudi, N
Jain, R
Reyar, S
Monif, T
2010 International journal of clinical pharmacology and therapeutics
9 (48), pp. 614-20
41. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. Hahnvajanawong, C
Boonyanugomol, W
Nasomyon, T
Loilome, W
Namwat, N
Anantachoke, N
Tassaneeyakul, W
Sripa, B
Namwat, W
Reutrakul, V
2010 World journal of gastroenterology : WJG
18 (16), pp. 2235-43
42. Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin. Sangviroon, A
Panomvana, D
Tassaneeyakul, W
Namchaisiri, J
2010 Drug metabolism and pharmacokinetics
6 (25), pp. 531-8
43. Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme. Feng, Q
Vannaprasaht, S
Peng, Y
Angsuthum, S
Avihingsanon, Y
Yee, VC
Tassaneeyakul, W
Weinshilboum, RM
2010 Biochemical pharmacology
7 (79), pp. 1053-61
44. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Tassaneeyakul, W
Tiamkao, S
Jantararoungtong, T
Chen, P
Lin, SY
Chen, WH
Konyoung, P
Khunarkornsiri, U
Auvichayapat, N
Pavakul, K
Kulkantrakorn, K
Choonhakarn, C
Phonhiamhan, S
Piyatrakul, N
Aungaree, T
Pongpakdee, S
Yodnopaglaw, P
2010 Epilepsia
5 (51), pp. 926-30
45. Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers. Kanjanawart, S
Gaysonsiri, D
Tangsucharit, P
Vannaprasaht, S
Phunikhom, K
Kaewkamson, T
Wattanachai, N
Tassaneeyakul, W
2011 International journal of clinical pharmacology and therapeutics
8 (49), pp. 525-30
46. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. Wattanachai, N
Polasek, TM
Heath, TM
Uchaipichat, V
Tassaneeyakul, W
Tassaneeyakul, W
Miners, JO
2011 European journal of clinical pharmacology
8 (67), pp. 815-24
47. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. Namwat, N
Puetkasichonpasutha, J
Loilome, W
Yongvanit, P
Techasen, A
Puapairoj, A
Sripa, B
Tassaneeyakul, W
Khuntikeo, N
Wongkham, S
2011 Journal of gastroenterology
5 (46), pp. 664-75
48. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Taesotikul, T
Dumrongsakulchai, W
Wattanachai, N
Navinpipat, V
Somanabandhu, A
Tassaneeyakul, W
Tassaneeyakul, W
2011 Drug metabolism and pharmacokinetics
2 (26), pp. 154-61
49. Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. Loilome, W
Juntana, S
Pinitsoontorn, C
Namwat, N
Tassaneeyakul, W
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 143-7
50. Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats. Taesotikul, T
Nakajima, M
Tassaneeyakul, W
Yokoi, T
2012 Xenobiotica; the fate of foreign compounds in biological systems
7 (42), pp. 641-8
51. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Kulkantrakorn, K
Tassaneeyakul, W
Tiamkao, S
Jantararoungtong, T
Prabmechai, N
Vannaprasaht, S
Chumworathayi, P
Chen, P
Sritipsukho, P
2012 Pain practice : the official journal of World Institute of Pain
3 (12), pp. 202-8
52. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. Hahnvajanawong, C
Chaiyagool, J
Seubwai, W
Bhudhisawasdi, V
Namwat, N
Khuntikeo, N
Sripa, B
Pugkhem, A
Tassaneeyakul, W
2012 World journal of gastroenterology : WJG
30 (18), pp. 3955-61
53. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit, P
Phanomsri, E
Namwat, N
Kampan, J
Tassaneeyakul, W
Loilome, W
Puapairoj, A
Khuntikeo, N
2012 Parasitology international
1 (61), pp. 162-6
54. High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma. Srimunta, U
Sawanyawisuth, K
Kraiklang, R
Pairojkul, C
Puapairoj, A
Titipungul, T
Hahnvajanawong, C
Tassaneeyakul, W
Wongkham, C
Wongkham, S
Vaeteewoottacharn, K
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 125-30
55. Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance. Wattanachai, N
Tassaneeyakul, W
Rowland, A
Elliot, DJ
Bowalgaha, K
Knights, KM
Miners, JO
2012 Drug metabolism and disposition: the biological fate of chemicals
5 (40), pp. 982-9
56. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Tangamornsuksan, W
Chaiyakunapruk, N
Somkrua, R
Lohitnavy, M
Tassaneeyakul, W
2013 JAMA dermatology
9 (149), pp. 1025-32
57. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. Vannaprasaht, S
Reungjui, S
Supanya, D
Sirivongs, D
Pongskul, C
Avihingsanon, Y
Tassaneeyakul, W
2013 Clinical therapeutics
11 (35), pp. 1762-9
58. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers. Kanjanawart, S
Gaysonsiri, D
Phunikom, K
Simasathiansopon, S
Tangsucharit, P
Vannaprasaht, S
Kaewkamson, T
Tassaneeyakul, W
2013 International journal of clinical pharmacology and therapeutics
3 (51), pp. 249-54
59. Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy. Auvichayapat, N
Rotenberg, A
Gersner, R
Ngodklang, S
Tiamkao, S
Tassaneeyakul, W
Auvichayapat, P
2013 Brain stimulation
4 (6), pp. 696-700
60. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Hershfield, MS
Callaghan, JT
Tassaneeyakul, W
Mushiroda, T
Thorn, CF
Klein, TE
Lee, MT
2013 Clinical pharmacology and therapeutics
2 (93), pp. 153-8
61. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. Jongthawin, J
Chusorn, P
Techasen, A
Loilome, W
Boonmars, T
Thanan, R
Puapairoj, A
Khuntikeo, N
Tassaneeyakul, W
Yongvanit, P
Namwat, N
2014 Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
8 (35), pp. 8051-64
62. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation. Sukasem, C
Puangpetch, A
Medhasi, S
Tassaneeyakul, W
2014 Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand
2 (32), pp. 111-23
63. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand. Makarawate, P
Chaosuwannakit, N
Vannaprasaht, S
Tassaneeyakul, W
Sawanyawisuth, K
2014 Singapore medical journal
4 (55), pp. 217-20
64. High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Thongchot, S
Yongvanit, P
Loilome, W
Seubwai, W
Phunicom, K
Tassaneeyakul, W
Pairojkul, C
Promkotra, W
Techasen, A
Namwat, N
2014 Asian Pacific journal of cancer prevention : APJCP
14 (15), pp. 5873-8
65. Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population. Saokaew, S
Tassaneeyakul, W
Maenthaisong, R
Chaiyakunapruk, N
2014 PloS one
4 (9), pp. e94294
66. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. Nakkam, N
Tiamkao, S
Kanjanawart, S
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2015 Drug metabolism and pharmacokinetics
4 (30), pp. 295-304
67. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Kongpan, T
Mahasirimongkol, S
Konyoung, P
Kanjanawart, S
Chumworathayi, P
Wichukchinda, N
Kidkeukarun, R
Preechakul, S
Khunarkornsiri, U
Bamrungram, W
Supharatwattanakun, B
Mootsikapun, P
Kwangsukstid, S
Denjanta, S
Vannaprasaht, S
Rungapiromnan, W
Suwankesawong, W
Tassaneeyakul, W
Tassaneeyakul, W
2015 Pharmacogenetics and genomics
8 (25), pp. 402-11
68. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Tassaneeyakul, W
Prabmeechai, N
Sukasem, C
Kongpan, T
Konyoung, P
Chumworathayi, P
Tiamkao, S
Khunarkornsiri, U
Kulkantrakorn, K
Saksit, N
Nakkam, N
Satapornpong, P
Vannaprasaht, S
Sangviroon, A
Mahasirimongkol, S
Wichukchinda, N
Rerkpattanapipat, T
Tassaneeyakul, W
2016 Pharmacogenetics and genomics
5 (26), pp. 225-34
69. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Saito, Y
Stamp, LK
Caudle, KE
Hershfield, MS
McDonagh, EM
Callaghan, JT
Tassaneeyakul, W
Mushiroda, T
Kamatani, N
Goldspiel, BR
Phillips, EJ
Klein, TE
Lee, M
2016 Clinical pharmacology and therapeutics
1 (99), pp. 36-7
70. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. Tempark, T
Satapornpong, P
Rerknimitr, P
Nakkam, N
Saksit, N
Wattanakrai, P
Jantararoungtong, T
Koomdee, N
Mahakkanukrauh, A
Tassaneeyakul, W
Suttisai, S
Pratoomwun, J
Klaewsongkram, J
Rerkpattanapipat, T
Sukasem, C
2017 Pharmacogenetics and genomics
12 (27), pp. 429-437
71. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Yothaisong, S
Namwat, N
Yongvanit, P
Khuntikeo, N
Puapairoj, A
Jutabha, P
Anzai, N
Tassaneeyakul, W
Tangsucharit, P
Loilome, W
2017 Parasitology international
4 (66), pp. 471-478
72. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. Wattanachai, N
Kaewmoongkun, S
Pussadhamma, B
Makarawate, P
Wongvipaporn, C
Kiatchoosakun, S
Vannaprasaht, S
Tassaneeyakul, W
2017 European journal of clinical pharmacology
8 (73), pp. 973-980
73. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Saksit, N
Tassaneeyakul, W
Nakkam, N
Konyoung, P
Khunarkornsiri, U
Chumworathayi, P
Sukasem, C
Suttisai, S
Piriyachananusorn, N
Tiwong, P
Chaiyakunapruk, N
Sawanyawisuth, K
Rerkpattanapipat, T
Tassaneeyakul, W
2017 Pharmacogenetics and genomics
7 (27), pp. 255-263
74. Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication Chunlertlith, K
Limpapanasit, U
Mairiang, P
Vannaprasaht, S
Tassaneeyakul, W
Sangchan, A
Sawadpanich, K
Suttichaimongkol, T
Pongpit, J
Pattarapongsin, M
2017 Asian Pacific journal of cancer prevention : APJCP
4 (18), pp. 927-932
75. Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. Koomdee, N
Pratoomwun, J
Jantararoungtong, T
Theeramoke, V
Tassaneeyakul, W
Klaewsongkram, J
Rerkpattanapipat, T
Santon, S
Puangpetch, A
Intusoma, U
Tempark, T
Deesudchit, T
Satapornpong, P
Visudtibhan, A
Sukasem, C
2017 Frontiers in pharmacology
(8), pp. 879
76. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. Chen, CB
Hsiao, YH
Wu, T
Hsih, MS
Tassaneeyakul, W
Jorns, TP
Sukasem, C
Hsu, CN
Su, SC
Chang, WC
Hui, RC
Chu, CY
Chen, YJ
Wu, CY
Hsu, CK
Chiu, TM
Sun, PL
Lee, HE
Yang, CY
Kao, PH
Yang, CH
Ho, HC
Lin, JY
Chang, YC
Chen, MJ
Lu, CW
Ng, CY
Kuo, KL
Lin, CY
Yang, CS
Chen, DP
Chang, PY
Wu, TL
Lin, YJ
Weng, YC
Kuo, TT
Hung, SI
Chung, WH
,
2017 Neurology
1 (88), pp. 78-86
77. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
. Nakkam, N
Tiamkao, S
Kanjanawart, S
Phunikhom, K
Tiamkao, S
Vannaprasaht, S
Tassaneeyakul, W
Tassaneeyakul, W
2017 International journal of clinical pharmacology and therapeutics
2 (55), pp. 177-185
78. Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. Nakkam, N
Konyoung, P
Kanjanawart, S
Saksit, N
Kongpan, T
Khaeso, K
Khunarkornsiri, U
Dornsena, A
Tassaneeyakul, W
Tassaneeyakul, W
2018 Frontiers in genetics
(9), pp. 277
79. Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. Chong, HY
Lim, YH
Prawjaeng, J
Tassaneeyakul, W
Mohamed, Z
Chaiyakunapruk, N
2018 Pharmacogenetics and genomics
2 (28), pp. 56-67
80. New Advances in Drug Hypersensitivity Research and Treatment. Tsai, YG
Chung, WH
Abe, R
Tassaneeyakul, W
2018 Journal of immunology research
(2018), pp. 9345078
81. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia. Khuankaew, C
Apaijai, N
Sawaddiruk, P
Jaiwongkam, T
Kerdphoo, S
Pongsiriwet, S
Tassaneeyakul, W
Chattipakorn, N
Chattipakorn, SC
2018 Free radical research
(), pp. 1-181
82. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Su, SC
Chen, CB
Chang, WC
Wang, CW
Fan, WL
Lu, LY
Nakamura, R
Saito, Y
Ueta, M
Kinoshita, S
Sukasem, C
Yampayon, K
Kijsanayotin, P
Nakkam, N
Saksit, N
Tassaneeyakul, W
Aihara, M
Lin, YJ
Chang, CJ
Wu, T
Hung, SI
Chung, WH
2019 Clinical pharmacology and therapeutics
2 (105), pp. 476-485
83. Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect. Leong, SL
Chaiyakunapruk, N
Tassaneeyakul, W
Arunmanakul, P
Nathisuwan, S
Lee, SWH
2019 International journal of cardiology
(280), pp. 190-197
84. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Pan, RY
Chu, MT
Wang, CW
Lee, YS
Lemonnier, F
Michels, AW
Schutte, R
Ostrov, DA
Chen, CB
Phillips, EJ
Mallal, SA
Mockenhaupt, M
Bellón, T
Tassaneeyakul, W
White, KD
Roujeau, JC
Chung, WH
Hung, SI
2019 Nature communications
1 (10), pp. 3569
85. The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. Wang, YH
Chen, CB
Tassaneeyakul, W
Saito, Y
Aihara, M
Choon, SE
Lee, HY
Chang, MM
Roa, FD
Wu, CW
Zhang, J
Nakkam, N
Konyoung, P
Okamoto-Uchida, Y
Cheung, CM
Huang, JW
Ji, C
Cheng, B
Hui, RC
Chu, CY
Chen, YJ
Wu, CY
Hsu, CK
Chiu, TM
Huang, YH
Lu, CW
Yang, CY
Lin, YT
Chi, MH
Ho, HC
Lin, JY
Yang, CH
Chang, YC
Su, SC
Wang, CW
Fan, WL
Hung, SI
Chung, WH
,
2019 Clinical pharmacology and therapeutics
1 (105), pp. 112-120
86. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Settheetham-Ishida, W
Yuenyao, P
Tassaneeyakul, W
Kanjanavirojkul, N
Thawmor, A
Kularbkaew, C
Hahvajanawong, C
Settheetham, D
Wattanathorn, J
Kashima, T
Ishida, T
Asian Pacific journal of cancer prevention : APJCP
1 (7), pp. 113-8

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Arylamine N-acetyltransferase-2 genotypes in the Thai population V Kukongviriyapan
A Prawan
W Tassaneyakul
J Aiemsa-ard
B Warasiha
2003 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
3.0 (55.0), pp. 278.0-281.0
43 0 0 0 0 0 43
2. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population V Kukongviriyapan
A Prawan
B Warasiha
W Tassaneyakul
J Aiemsa-ard
2003 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
4.0 (59.0), pp. 277.0-281.0
20 0 0 0 0 0 20
3. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines Nisana Tepsiri
Liengchai Chaturat
Banchob Sripa
Wises Namwat
Sopit Wongkham
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2005 WORLD JOURNAL OF GASTROENTEROLOGY
18.0 (11.0), pp. 2748.0-2753.0
71 0 0 0 0 0 71
4. Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines Nisana N. Tepsiri
Watcharin Loilome
Piyawan Amimanan
Patcharee Jearanaikoon
Wichittra Tassaneeyakul
2006 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(21.0), pp. A95-A95
0 0 0 0 0 0 0
5. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations Wichittra Tassaneeyakul
Werawath Mahatthanatrakul
Kanokporn Niwatananun
Kesara Na-Bangchang
Arporn Tawalee
Nathawut Krikreangsak
Utaiwan Cykleng
Wongwiwat Tassaneeyakul
2006 DRUG METABOLISM AND PHARMACOKINETICS
4.0 (21.0), pp. 286.0-290.0
46 0 0 0 0 0 46
6. Effect of B-thalassemia/HbE disease on activity of cytochrome P450s Nuntiya Somparn
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Upa Kukongviriyapan
Arunee Jetsrisuparb
2006 DRUG METABOLISM REVIEWS
(38.0), pp. 116.0-116.0
0 0 0 0 0 0 0
7. Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis Suthipun Jitpimolmard
Kittisak Sawanyawisuth
Nimit Morakote
Athasit Vejjajiva
Montien Puntumetakul
Kanokwan Sanchaisuriya
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
Narumanas Korwanich
2007 PARASITOLOGY RESEARCH
6.0 (100.0), pp. 1293.0-1296.0
77 0 0 0 0 0 77
8. COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS Suda Vannaprasaht
Somsak Tiamkao
Aporanee Chaiyakum
Chedsada Noppawinyoowong
Detpon Preechagoon
Sirimas Kanjanawat
Wichittra Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 93.0-93.0
0 0 0 0 0 0 0
9. COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS Sirimas Kanjanawart
Suda Vannaprasaht
Panot Tangsucharit
Dhanu Gaysornsiri
Siriporn Tiamkao
Bunkerd Kongyingyoes
Roongpet Tangrassameeprasert
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 87.0-87.0
0 0 0 0 0 0 0
10. INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Vichien Attakornvattana
Aimon Somanabandhu
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 219.0-219.0
0 0 0 0 0 0 0
11. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients Nuntiya Somparn
Upa Kukongviriyapan
Wichittra Tassaneeyakul
Arunee Jetsrisuparb
Veerapol Kukongviriyapan
2007 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
1.0 (63.0), pp. 43.0-50.0
31 0 0 0 0 0 31
12. THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS Susothorn Angsuthum
Wichittra Tassaneeyakul
Cholatip Pongskul
Dhavee Sirivongs
Wongwiwat Tassaneeyakul
Yingyos Avihingsanon
Suda Vannaprasaht
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 269.0-269.0
0 0 0 0 0 0 0
13. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines Nisana Namwat
Piyawan Amimanan
Watcharin Loilome
Patcharee Jearanaikoon
Banchob Sripa
Vajarabhongsa Bhudhisawasdi
Wichittra Tassaneeyakul
2008 CHEMOTHERAPY
5.0 (54.0), pp. 343.0-351.0
48 0 0 0 0 0 48
14. GENETIC POLYMORPHISM OF DRUG METABOLIZING ENZYMES IN THAIS Wichittra Tassaneeyakul 2008 DRUG METABOLISM REVIEWS
(40.0), pp. 16.0-16.0
0 0 0 0 0 0 0
15. CADMIUM EXPOSURE IN THAI POPULATIONS FROM CENTRAL, NORTHERN AND NORTHEASTERN THAILAND AND THE EFFECTS OF FOOD CONSUMPTION ON CADMIUM LEVELS Roongnapa Apinan
Soisangwan Satarug
Ronnatrai Ruengweerayut
Wichittra Tassaneeyakul
Kesara Na-Bangchang
2009 SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
1.0 (40.0), pp. 177.0-186.0
13 0 0 0 0 0 13
16. Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population Thawinee Iantararoungtong
Somsak Tiamkao
Suda Vannaprasaht
Kasemsin Pavakul
Narong Auvichayapat
Charoen Choonhakarn
Wichittra Tassaneeyakul
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 57.0-57.0
2 0 0 0 0 0 2
17. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking Wiratchanee Mahavorasirikul
Wichittra Tassaneeyakul
Soisagwan Satarug
Ronnatrai Reungweerayut
Chacrin Na-Bangchang
Kesara Na-Bangchang
2009 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
4.0 (65.0), pp. 377.0-384.0
19 0 0 0 0 0 19
18. Effect of Albumin on In Vitro Omeprazole Kinetics in Human Liver Microsomes Nitsupa Wattanachai
David J. Elliot
Wichittra Tassaneeyakul
John O. Miners
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 32.0-32.0
0 0 0 0 0 0 0
19. Expression Profile of Genes Involved in 5-Fluorouracil Metabolic Pathway as Predictive Parameters for 5-Fluorouracil Response in Cholangiocarcinoma Jariya Chaiyagool
Chariya Hahnvajanawong
Banchob Sripa
Vajarapong Bhudhisawasdi
Narong Khuntikeo
Ake Pugkhem
Siri Chau-in
Wichittra Tassaneeyakul
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 40.0-40.0
0 0 0 0 0 0 0
20. Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand Suda Vannaprasaht
Susothorn Angsuthum
Yingyos Avihingsanon
Dhavee Sirivongs
Cholatip Pongskul
Pattarapong Makarawate
Kearkiat Praditpornsilpa
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009 CLINICAL THERAPEUTICS
7.0 (31.0), pp. 1524.0-1533.0
22 0 0 0 0 0 22
21. Influence of Genetic and Environmental Factors on Cytochrome P450-mediated Nicotine Metabolism in Thai Population Wiratchanee Mahavorasirikul
Rungnapa Apinan
Soisungwan Satarug
Wichittra Tassaneeyakul
Kesara Na-Bangchang
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 75.0-75.0
0 0 0 0 0 0 0
22. Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus Theerada Taesotikul
Aimon Somanabandhu
Vichien Navinpipatana
Sirimas Kanjanawart
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 39.0-39.0
0 0 0 0 0 0 0
23. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population Wichittra Tassaneeyakul
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Somsak Tiamkao
Usanee Khunarkornsiri
Pachadaporn Chucherd
Parinya Konyoung
Suda Vannaprasaht
Charoen Choonhakarn
Pornrith Pisuttimarn
Alisara Sangviroon
Wongwiwat Tassaneeyakul
2009 PHARMACOGENETICS AND GENOMICS
9.0 (19.0), pp. 704.0-709.0
345 0 0 0 0 0 345
24. The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population Roongnapa Apinan
Wichittra Tassaneeyakul
Wiratchanee Mahavorasirikul
Soisangwang Satarug
Sirimas Kajanawart
Suda Vannaprasaht
Ronnatrai Ruenweerayut
Kesara Na-Bangchang
2009 ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
3.0 (28.0), pp. 420.0-424.0
1 0 0 0 0 0 1
25. Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 Wongwiwat Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Pao-Yu Lin
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Pachadaporn Chucherd
Suda Vannaprasaht
Charoen Choonhakarn
Alisara Sangviroon
Wichittra Tassaneeyakul
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 253.0-254.0
0 0 0 0 0 0 0
26. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines Chariya Hahnvajanawong
Wongwarut Boonyanugomol
Tapanawan Nasomyon
Watcharin Loilome
Nisana Namwat
Natthinee Anantachoke
Wichittra Tassaneeyakul
Banchob Sripa
Wises Namwat
Vichai Reutrakul
2010 WORLD JOURNAL OF GASTROENTEROLOGY
18.0 (16.0), pp. 2235.0-2243.0
39 0 0 0 0 0 39
27. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Wichittra Tassaneeyakul
Somsak Tiamkao
Thawinee Jantararoungtong
Pei Chen
Shu-Yi Lin
Wei-Hsuan Chen
Parinya Konyoung
Usanee Khunarkornsiri
Narong Auvichayapat
Kasemsin Pavakul
Kongkiat Kulkantrakorn
Charoen Choonhakarn
Siranun Phonhiamhan
Namfon Piyatrakul
Thiti Aungaree
Sunsanee Pongpakdee
Praphan Yodnopaglaw
2010 EPILEPSIA
5.0 (51.0), pp. 926.0-930.0
232 0 0 0 0 0 232
28. Association of HLA-B*1502 and severe cutaneous adverse reactions caused by aromatic antiepileptic drugs Wichittra Tassaneeyakul
Somsak Tiamkao
Napat Prabmeechai
Thawinee Jantararoungtong
Pei Chen
Shu-Yi Lin
Wei-Hsuan Chen
Pansu Chumworathayi
Usanee Khunarkornsiri
Parinya Konyoung
Alisara Sangviroon
Patcharee Kanjanawat
Arkhom Arayawhichanont
Charoen Choonhakarn
Kongkiat Kulkantrakorn
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 255.0-255.0
2 0 0 0 0 0 2
29. OPTIMISING CLOZAPINE THERAPY: A NEW MODEL OF CLOZAPINE THERAPEUTIC DRUG MONITORING John Ray
Gillian Campbell
Tony Richardson
Gill Erickson
Vaughan Carr
Peter Rofe
Wichittra Tassaneeyakul
Gary Graham
2010 AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
(44.0), pp. A26-A26
0 0 0 0 0 0 0
30. Pharmacokinetic and Pharmacodynamic Variation Associated with VKORC1 and CYP2C9 Polymorphisms in Thai Patients Taking Warfarin Alisara Sangviroon
Duangchit Panomvana
Wichittra Tassaneeyakul
Jule Namchaisiri
2010 DRUG METABOLISM AND PHARMACOKINETICS
6.0 (25.0), pp. 531.0-538.0
29 0 0 0 0 0 29
31. The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation Nitsupa Wattanachai
Wichittra Tassaneeyakul
Verawan Uchaipichat
John O. Miners
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 77.0-78.0
0 0 0 0 0 0 0
32. Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme Qiping Feng
Suda Vannaprasaht
Yi Peng
Susothorn Angsuthum
Yingyos Avihingsanon
Vivien C. Yee
Wichittra Tassaneeyakul
Richard M. Weinshilboum
2010 BIOCHEMICAL PHARMACOLOGY
7.0 (79.0), pp. 1053.0-1061.0
24 0 0 0 0 0 24
33. HLA genetic polymorphism and severe cutaneous adverse drug reactions in a Thai population Wichittra Tassaneeyakul 2011 DRUG METABOLISM REVIEWS
(43.0), pp. 17.0-17.0
0 0 0 0 0 0 0
34. Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines Chariya Hahnvajanawong
Supaluk Ketnimit
Wongwarut Boonyanugomol
Kovit Pattanapanyasat
Yaovalux Chamgramol
Banchob Sripa
Nisana Namwat
Khosit Pinmai
Wichittra Tassaneeyakul
Vichai Reutakul
2011 ASIAN BIOMEDICINE
6.0 (5.0), pp. 775.0-785.0
5 0 0 0 0 0 5
35. Inhibition of human CYP1A2 activity by Thai medicinal plants with promising activities against cholangiocarcinoma Wiratchanee Mahavorasirikul
Vithoon Viyanant
Wichittra Tassaneeyakul
Kesara Na-Bangchang
2011 JOURNAL OF PHARMACOLOGICAL SCIENCES
(115.0), pp. 279P-279P
0 0 0 0 0 0 0
36. Inhibitory Effects of Phyllanthus amarus and Its Major Lignans on Human Microsomal Cytochrome P450 Activities: Evidence for CYP3A4 Mechanism-Based Inhibition Theerada Taesotikul
Weeraya Dumrongsakulchai
Nitsupa Wattanachai
Vichien Navinpipat
Aimon Somanabandhu
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2011 DRUG METABOLISM AND PHARMACOKINETICS
2.0 (26.0), pp. 154.0-161.0
36 0 0 0 0 0 36
37. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Nitsupa Wattanachai
Thomas M. Polasek
Tahlia M. Heath
Verawan Uchaipichat
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
John O. Miners
2011 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
8.0 (67.0), pp. 815.0-824.0
46 0 0 0 0 0 46
38. Effect of Albumin on Human Liver Microsomal and Recombinant CYP1A2 Activities: Impact on In Vitro-In Vivo Extrapolation of Drug Clearance Nitsupa Wattanachai
Wichittra Tassaneeyakul
Andrew Rowland
David J. Elliot
Kushari Bowalgaha
Kathleen M. Knights
John O. Miners
2012 DRUG METABOLISM AND DISPOSITION
5.0 (40.0), pp. 982.0-989.0
37 0 0 0 0 0 37
39. Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats Theerada Taesotikul
Miki Nakajima
Wichittra Tassaneeyakul
Tsuyoshi Yokoi
2012 XENOBIOTICA
7.0 (42.0), pp. 641.0-648.0
4 0 0 0 0 0 4
40. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma Puangrat Yongvanit
Emorn Phanomsri
Nisana Namwat
Jureeporn Kampan
Wichittra Tassaneeyakul
Watcharin Loilome
Anucha Puapairoj
Narong Khuntikeo
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 162.0-166.0
7 0 0 0 0 0 7
41. High Expression of ABCC1 Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma Umaporn Srimunta
Kanlayanee Sawanyawisuth
Ratthaphol Kraiklang
Chawalit Pairojkul
Anucha Puapairoj
Tanin Titipungul
Chariya Hahnvajanawong
Wichittra Tassaneeyakul
Chaisiri Wongkham
Sopit Wongkham
Kulthida Vaeteewoottacharn
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 125.0-130.0
15 0 0 0 0 0 15
42. HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain Kongkiat Kulkantrakorn
Wichittra Tassaneeyakul
Somsak Tiamkao
Thawinee Jantararoungtong
Napat Prabmechai
Suda Vannaprasaht
Pansu Chumworathayi
Pei Chen
Paskorn Sritipsukho
2012 PAIN PRACTICE
3.0 (12.0), pp. 202.0-208.0
73 0 0 0 0 0 73
43. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil Chariya Hahnvajanawong
Jariya Chaiyagool
Wunchana Seubwai
Vajarabhongsa Bhudhisawasdi
Nisana Namwat
Narong Khuntikeo
Banchob Sripa
Ake Pugkhem
Wichittra Tassaneeyakul
2012 WORLD JOURNAL OF GASTROENTEROLOGY
30.0 (18.0), pp. 3955.0-3961.0
20 0 0 0 0 0 20
44. Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells Watcharin Loilome
Sirinun Juntana
Chadamas Pinitsoontorn
Nisana Namwat
Wichittra Tassaneeyakul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 143.0-147.0
3 0 0 0 0 0 3
45. The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients Pattarapong Makarawate
Narumol Chaosuwannakit
Suda Vannaprasaht
Koo Seok Hwee
Edmund Jon Deoon Lee
Wichittra Tassaneeyakul
2012 CIRCULATION
23.0 (126.0), pp. 2798.0-2798.0
0 0 0 0 0 0 0
46. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers Sirimas Kanjanawart
Dhanu Gaysonsiri
Katcharin Phunikom
Sontaya Simasathiansopon
Panot Tangsucharit
Suda Vannaprasaht
Thanawat Kaewkamson
Wichittra Tassaneeyakul
2013 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
3.0 (51.0), pp. 249.0-254.0
2 0 0 0 0 0 2
47. Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation Suda Vannaprasaht
Sirirat Reungjui
Darika Supanya
Dhavee Sirivongs
Cholatip Pongskul
Yingyos Avihingsanon
Wichittra Tassaneeyakul
2013 CLINICAL THERAPEUTICS
11.0 (35.0), pp. 1762.0-1769.0
31 0 0 0 0 0 31
48. Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis A Systematic Review and Meta-analysis Wimonchat Tangamornsuksan
Nathorn Chaiyakunapruk
Ratchadaporn Somkrua
Manupat Lohitnavy
Wichittra Tassaneeyakul
2013 JAMA DERMATOLOGY
9.0 (149.0), pp. 1025.0-1032.0
104 0 0 0 0 0 104
49. Transcranial Direct Current Stimulation for Treatment of Refractory Childhood Focal Epilepsy Narong Auvichayapat
Alexander Rotenberg
Roman Gersner
Sudarat Ngodklang
Somsak Tiamkao
Wichittra Tassaneeyakul
Paradee Auvichayapat
2013 BRAIN STIMULATION
4.0 (6.0), pp. 696.0-700.0
70 0 0 0 0 0 70
50. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand Pattarapong Makarawate
Narumol Chaosuwannakit
Suda Vannaprasaht
Wichittra Tassaneeyakul
Kittisak Sawanyawisuth
2014 SINGAPORE MEDICAL JOURNAL
4.0 (55.0), pp. 217.0-220.0
12 0 0 0 0 0 12
51. COMPARATIVE ANTIPLATELET AGGREGATION EFFECT OF TWO CLOPIDOGREL PRODUCTS UNDER STEADY STATE CONDITION IN HEALTHY VOLUNTEERS S. Tiamkao
N. Nakkam
S. Kanjanawart
W. Tassaneeyakul
2014 CEREBROVASCULAR DISEASES
(37.0), pp. 341.0-341.0
0 0 0 0 0 0 0
52. Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population Surasak Saokaew
Wichittra Tassaneeyakul
Ratree Maenthaisong
Nathorn Chaiyakunapruk
2014 PLOS ONE
4.0 (9.0), pp.
81 0 0 0 0 0 81
53. High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis Suyanee Thongchot
Puangrat Yongvanit
Watcharin Loilome
Wanchana Seubwai
Kutcharin Phunicom
Wichittra Tassaneeyakul
Chawalit Pairojkul
Wisuttiphong Promkotra
Anchalee Techasen
Nisana Namwat
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
14.0 (15.0), pp. 5873.0-5878.0
37 0 0 0 0 0 37
54. PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression Jurairat Jongthawin
Porncheera Chusorn
Anchalee Techasen
Watcharin Loilome
Thidarut Boonmars
Raynoo Thanan
Anucha Puapairoj
Narong Khuntikeo
Wichittra Tassaneeyakul
Puangrat Yongvanit
Nisana Namwat
2014 TUMOR BIOLOGY
8.0 (35.0), pp. 8051.0-8064.0
10 0 0 0 0 0 10
55. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges opportunities and clinical implementation Chonlaphat Sukasem
Apichaya Puangpetch
Sadeep Medhasi
Wichittra Tassaneeyakul
2014 ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
2.0 (32.0), pp. 111.0-123.0
58 0 0 0 0 0 58
56. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions Thachanan Kongpan
Surakameth Mahasirimongkol
Parinya Konyoung
Sirimas Kanjanawart
Pansu Chumworathayi
Nuanjun Wichukchinda
Runglak Kidkeukarun
Suphanlinee Preechakul
Usanee Khunarkornsiri
Warawut Bamrungram
Butsaban Supharatwattanakun
Piroon Mootsikapun
Supanida Kwangsukstid
Sukanda Denjanta
Suda Vannaprasaht
Watcharee Rungapiromnan
Wimon Suwankesawong
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015 PHARMACOGENETICS AND GENOMICS
8.0 (25.0), pp. 402.0-411.0
39 1 0 0 0 0 40
57. The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2015 DRUG METABOLISM AND PHARMACOKINETICS
4.0 (30.0), pp. 295.0-304.0
6 0 0 0 0 0 6
58. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population Wichittra Tassaneeyakul
Napat Prabmeechai
Chonlaphat Sukasem
Thachanan Kongpan
Parinya Konyoung
Pansu Chumworathayi
Somsak Tiamkao
Usanee Khunarkornsiri
Kongkiat Kulkantrakorn
Niwat Saksit
Nontaya Nakkam
Patompong Satapornpong
Suda Vannaprasaht
Alisara Sangviroon
Surakameth Mahasirimongkol
Nuanjun Wichukchinda
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2016 PHARMACOGENETICS AND GENOMICS
5.0 (26.0), pp. 225.0-234.0
65 0 0 0 0 0 65
59. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update Y. Saito
L. K. Stamp
K. E. Caudle
M. S. Hershfield
E. M. McDonagh
J. T. Callaghan
W. Tassaneeyakul
T. Mushiroda
N. Kamatani
B. R. Goldspiel
E. J. Phillips
T. E. Klein
M. T. M. Lee
2016 CLINICAL PHARMACOLOGY & THERAPEUTICS
1.0 (99.0), pp. 36.0-37.0
87 0 0 0 0 0 87
60. Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication Uaepong Limpapanasit
Pisaln Mairiang
Kitti Chunlertlith
Wattana Sukeepaisarnjaroen
Suda Vannaprasaht
Wichittra Tassaneeyakul
Apichat Sangchan
Kookwan Sawadpanich
Tanita Suttichaimongkol
2016 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(31.0), pp. 78.0-78.0
0 0 0 0 0 0 0
61. Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population Napatrupron Koomdee
Jirawat Pratoomwun
Thawinee Jantararoungtong
Voralaksana Theeramoke
Wichittra Tassaneeyakul
Jettanong Klaewsongkram
Ticha Rerkpattanapipat
Siwalee Santon
Apichaya Puangpetch
Utcharee Intusoma
Therdpong Tempark
Tayard Deesudchit
Patompong Satapornpong
Anannit Visudtibhan
Chonlaphat Sukasem
2017 FRONTIERS IN PHARMACOLOGY
(8.0), pp.
17 0 0 0 0 0 17
62. Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers Nontaya Nakkam
Somsak Tiamkao
Sirimas Kanjanawart
Kutcharin Phunikhom
Siriporn Tiamkao
Suda Vannaprasaht
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2017 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2.0 (55.0), pp. 177.0-185.0
0 0 0 0 0 0 0
63. Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions Niwat Saksit
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Wongwiwat Tassaneeyakul
Pansu Chumworathayi
Sirimas Kanjanawart
Chonlaphat Sukasem
Alisara Sangviroon
Oranuch Pattanacheewapull
Wichittra Tassaneeyakul
2017 JOURNAL OF IMMUNOLOGY RESEARCH
(), pp.
4 0 0 0 0 0 4
64. CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION Wichittra Tassaneeyakul
Parinya Konyoung
Thachanan Kongpan
Pansu Chumworathayi
Nontaya Nakkam
Suda Vannaprasaht
Somsak Tiamkao
Chonlaphat Sukasem
Patompong Satapornpong
Wongwiwat Tassaneeyakul
2017 DRUG METABOLISM AND PHARMACOKINETICS
1.0 (32.0), pp. S85-S86
0 0 0 0 0 0 0
65. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population Therdpong Tempark
Patompong Satapornpong
Pawinee Rerknimitr
Nontaya Nakkam
Niwat Saksit
Penpun Wattanakrai
Thawinee Jantararoungtong
Napatrupron Koomdee
Ajanee Mahakkanukrauh
Wichittra Tassaneeyakul
Sumitra Suttisai
Jirawat Pratoomwun
Jettanong Klaewsongkram
Ticha Rerkpattanapipat
Chonlaphat Sukasem
2017 PHARMACOGENETICS AND GENOMICS
12.0 (27.0), pp. 429.0-437.0
25 0 0 0 0 0 25
66. DEVELOPMENT OF A PHARMACOGENETICS-BASED WARFARIN DOSING ALGORITHM FOR THAI PATIENTS Nitsupa Wattanachai
Sutthida Kaewmoongkun
Wichittra Tassaneeyakul
2017 DRUG METABOLISM AND PHARMACOKINETICS
1.0 (32.0), pp. S86-S86
0 0 0 0 0 0 0
67. GENETIC MARKERS FOR SEVERE CUTANEOUS ADVERSE DRUG REACTIONS IN THAI POPULATION AND THEIR CLINICAL STATUS Wichittra Tassaneeyakul 2017 DRUG METABOLISM AND PHARMACOKINETICS
1.0 (32.0), pp. S16-S16
0 0 0 0 0 0 0
68. HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI Chonlaphat Sukasem
Therdpong Tempark
Patompong Satapornpong
Pawinee Rerknimitr
Jettanong Klaewsongkram
Wichittra Tassaneeyakul
2017 HLA
6.0 (89.0), pp. 470.0-471.0
0 0 0 0 0 0 0
69. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance Supak Yothaisong
Nisana Namwat
Puangrat Yongvanit
Narong Khuntikeo
Anucha Puapairoj
Promsuk Jutabha
Naohiko Anzai
Wichittra Tassaneeyakul
Panot Tangsucharit
Watcharin Loilome
2017 PARASITOLOGY INTERNATIONAL
4.0 (66.0), pp. 471.0-478.0
6 0 0 0 0 0 6
70. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians Chun-Bing Chen
Yi-Hsin Hsiao
Tony Wu
Mo-Song Hsih
Wichittra Tassaneeyakul
Teekayu P. Jorns
Chonlaphat Sukasem
Chien-Ning Hsu
Shih-Chi Su
Wan-Chun Chang
Rosaline Chung-Yee Hui
Chia-Yu Chu
Yi-Ju Chen
Ching-Ying Wu
Chao-Kai Hsu
Tsu-Man Chiu
Pei-Lun Sun
Hua-En Lee
Chin-Yi Yang
Pei-han Kao
Chih-Hsun Yang
Hsin-Chun Ho
Jing-Yi Lin
Ya-Ching Chang
Ming-Jing Chen
Chun-Wei Lu
Chau Yee Ng
Kang-Ling Kuo
Chien-yio Lin
Ching-Sheng Yang
Ding-Ping Chen
Pi-Yueh Chang
Tsu-Lan Wu
Yu-Jr Lin
Yi-Ching Weng
Tseng-tong Kuo
Shuen-Iu Hung
Wen-Hung Chung
2017 NEUROLOGY
1.0 (88.0), pp. 78.0-86.0
70 0 0 0 0 0 70
71. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population Niwat Saksit
Wichittra Tassaneeyakul
Nontaya Nakkam
Parinya Konyoung
Usanee Khunarkornsiri
Pansu Chumworathayi
Chonlaphat Sukasem
Sumitra Suttisai
Napacha Piriyachananusorn
Pawinee Tiwong
Nathorn Chaiyakunapruk
Kittisak Sawanyawisuth
Ticha Rerkpattanapipat
Wongwiwat Tassaneeyakul
2017 PHARMACOGENETICS AND GENOMICS
7.0 (27.0), pp. 255.0-263.0
12 0 0 0 0 0 12
72. SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome Pattarapong Makarawate
Narumol Chaosuwannakit
Suda Vannaprasaht
Dujdao Sahasthas
Seok Hwee Koo
Edmund Jon Deoon Lee
Wichittra Tassaneeyakul
Hector Barajas-Martinez
Dan Hu
Kittisak Sawanyawisuth
2017 JOURNAL OF THE AMERICAN HEART ASSOCIATION
6.0 (6.0), pp.
15 0 0 0 0 0 15
73. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients Nitsupa Wattanachai
Sutthida Kaewmoongkun
Burabha Pussadhamma
Pattarapong Makarawate
Chaiyasith Wongvipaporn
Songsak Kiatchoosakun
Suda Vannaprasaht
Wichittra Tassaneeyakul
2017 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
8.0 (73.0), pp. 973.0-980.0
4 0 0 0 0 0 4
74. Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population Huey Yi Chong
Yi Heng Lim
Juthamas Prawjaeng
Wichittra Tassaneeyakul
Zahurin Mohamed
Nathorn Chaiyakunapruk
2018 PHARMACOGENETICS AND GENOMICS
2.0 (28.0), pp. 56.0-67.0
6 0 0 0 0 0 6
75. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminai neuralgia Chutikorn Khuankaew
Nattayaporn Apaijai
Passakorn Sawaddiruk
Thidarat Jaiwongkann
Sasiwan Kerdphoo
Surawut Pongsiriwet
Wichittra Tassaneeyakul
Nipon Chattipakorn
Siriporn C. Chattipakorn
2018 FREE RADICAL RESEARCH
4.0 (52.0), pp. 415.0-425.0
2 0 0 0 0 0 2
76. HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population Nontaya Nakkam
Parinya Konyoung
Sirimas Kanjanawart
Niwat Saksit
Thachanan Kongpan
Kanyarat Khaeso
Usanee Khunarkornsiri
Areerat Domsena
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
2018 FRONTIERS IN GENETICS
(9.0), pp.
2 0 0 0 0 0 2
77. New Advances in Drug Hypersensitivity Research and Treatment Yi-Giien Tsai
Wen-Hung Chung
Riichiro Abe
Wichittra Tassaneeyakul
2018 JOURNAL OF IMMUNOLOGY RESEARCH
(), pp.
0 0 0 0 0 0 0
78. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians Shih-Chi Su
Chun-Bing Chen
Wan-Chun Chang
Chuang-Wei Wang
Wen-Lang Fan
Lai-Ying Lu
Ryosuke Nakamura
Yoshiro Saito
Mayumi Ueta
Shigeru Kinoshita
Chonlaphat Sukasem
Kittika Yampayon
Pornpimol Kijsanayotin
Nontaya Nakkam
Niwat Saksit
Wichittra Tassaneeyakul
Michiko Aihara
Yu- Lin
Chee-Jen Chang
Tony Wu
Sheen-Iu Hung
Wen-Hung Chung
2019 CLINICAL PHARMACOLOGY & THERAPEUTICS
2.0 (105.0), pp. 476.0-485.0
9 0 0 0 0 0 9
79. Identification of drug-specific public TCR driving severe cutaneous adverse reactions Ren-You Pan
Mu-Tzu Chu
Chuang-Wei Wang
Yun-Shien Lee
Francois Lemonnier
Aaron W. Michels
Ryan Schutte
David A. Ostrov
Chun-Bing Chen
Elizabeth Jane Phillips
Simon Alexander Mallal
Maja Mockenhaupt
Teresa Bellon
Wichittra Tassaneeyakul
Katie D. White
Jean-Claude Roujeau
Wen-Hung Chung
Shuen-Iu Hung
2019 NATURE COMMUNICATIONS
(10.0), pp.
4 0 0 0 0 0 4
80. Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect Siew Lian Leong
Nathorn Chaiyakunapruk
Wichittra Tassaneeyakul
Poukwan Arunmanakul
Surakit Nathisuwan
Shaun Wen Huey Lee
2019 INTERNATIONAL JOURNAL OF CARDIOLOGY
(280.0), pp. 190.0-197.0
2 0 0 0 0 0 2
81. The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label Yu-Hsin Wang
Chun-Bing Chen
Wichittra Tassaneeyakul
Yoshiro Saito
Michiko Aihara
Siew Eng Choon
Haur Yueh Lee
Mimi Mee Chang
Francisca D. Roa
Cheng-Wei Wu
Jing Zhang
Nontaya Nakkam
Parinya Konyoung
Yoshimi Okamoto-Uchida
Christina Man-tung Cheung
Jin-wen Huang
Chao Ji
Bo Cheng
Rosaline Chung-Yee Hui
Chia-Yu Chu
Yi-Ju Chen
Ching-Ying Wu
Chao-Kai Hsu
Tsu-Man Chiu
Yu-Huei Huang
Chun-Wei Lu
Chin-Yi Yang
Yi-Ting Lin
Min-Hui Chi
Hsin-Chun Ho
Jing-Yi Lin
Chih-Hsun Yang
Ya-Ching Chang
Shih-Chi Su
Chuang Wei Wang
Wen-Lang Fan
Shuen-Iu Hung
Wen-Hung Chung
2019 CLINICAL PHARMACOLOGY & THERAPEUTICS
1.0 (105.0), pp. 112.0-120.0
10 0 0 0 0 0 10

Title Authors Year Journal title
1. Towards Understanding Cytochromes P450 Wichittra Tassaneeyakul
Wongwiwat Tassaneeyakul
Khan Kaen Khon Kaen University
1996 Thai Journal of Pharmacology
(18), pp. 43-65
2. Antigastric Ulcer Effect of Turmeric in Rats Patchareewan Pannangpetch
Jintanaporn Watanathorn
Orapin Phasuriwong
Wichittra Tassaneeyakul
Bunkerd Kongyingyoes
2000 Srinagarind Medical Journal
(15 No 4), pp. 250-254
3. Genetic Polymorphism of Cytochrome P450 2C19 Wichittra Tassaneeyakul
Arporn Tawalee
Wongwiwat Tassaneeyakul
2000 Thai Journal of Pharmacology
(22 No 2), pp. 121-136
4. Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population Wichittra Tassaneeyakul
Arpom Tawalee
Veerapol Kukongviriyapan
Wongwiwat Tassaneeyakul
2000 Thai Journal of Pharmacology
Supplement 1 (22), pp. S79
5. Arylamine N-Acetyltransferase-2 Genotype Polymorphism in Thai Population Auemduan Prawan
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Bunkerd Kongyingyose
Thailand 40002 Khon Kaen
2001 Thai Journal of Pharmacology
Supplement 1 (23), pp. S112
6. Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers Wongwiwat Tassaneeyakul
Arporn Tawalee
Watchara Boonsawat
Katcharin Phunikom
Veerapol Kukongviriyapan
Prapawadee Puapairoj
Wichittra Tassaneeyakul
2002 Srinagarind Medical Journal
(17 No 4), pp. 254-260
7. Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population Somrudee Srimartpirom
Wongwiwat Tassaneeyakul
Veerapol Kukongwiriyapan
Wichittra Tassaneeyakul
2002 Thai Journal of Pharmacology
Supplement 1 (24), pp. 137
8. Screening for Naturally Occurring Inhibitors of Arylamine N-Acetyltransferase 1 Activity Ninatthanan Phromsopha
Veerapol Kukongviriyapan
Wichittra Tassaneeyakul
Upa Kukongviriyapan
2002 Thai Journal of Pharmacology
Supplement 1 (24), pp. 139
9. Evaluation of CYP1A2 Activity in Thalassemia Patients Veerapol Kukongviriyapan
Laddawan Senggunprai
Upa Kukongviriyapan
Arunee Jetsrisuparb
Wichittra Tassaneyakul
Khon Kaen 40002 Khon Kaen University
2003 Thai Journal of Pharmacology
(25 No 1), pp. 80
10. Oxidative Stress and Protein Damage in Thalassemia Patients and Smokers Nuntiya Somparn
Veerapol Kukongviriyapan
Wichitra Tassaneeyakul
Upa Kukongviriyapan
KhonKaen Khon Kaen University
2004 Thai Journal of Pharmacology
(26 No 1), pp. 62
11. Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines Nisana Namwat
Banchob Sripa
Watcharin Loilome
Vajarabhongsa Bhudisawadi
Wichittra Tassaneeyakul
2007 Srinagarind Medical Journal
(22 No 3), pp. 230-234
12. Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients Wichittra Tassaneeyakul
Khanogwan Kittiwattanagul
Siriporn Tiamkao
Jureeporn Kampan
Suda Vannaprasaht
Wannapa Haewdee
Prapawadee Puapairoj
Bunkerd Kongyingyoes
Wongwiwat Tassaneeyakul
2007 Srinagarind Medical Journal
(22 No 1), pp. 16-23
13. Herb and Drug Interaction Wichittra Tassaneeyakul
Weeraya Dumrongsakunchai
Wongwiwat Tassaneeyakul
2008 Srinagarind Medical Journal
(23 No 2), pp. 223-228
14. Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers Sirimas Kanjanawart
Bunkerd Kongyingyoes
Dhanu Gaysornsiri
Panot Tangsucharit
Prapawadee Puapairoj
Suda Vannaprasaht
Siriporn Tiamkao
Wichittra Tassaneeyakul
2008 Srinagarind Medical Journal
(23 No 1), pp. 38-44
15. Monoclonal Antibody: Targeted Therapy of Cancer Sirimas Kanjanawart
Wichittra Tassaneeyakul
2008 Srinagarind Medical Journal
(23 No 4), pp. 440-446
16. Pharmacogenomics Wichittra Tassaneeyakul 2009 Srinagarind Medical Journal
(24 No 1), pp. 64-71
17. Carbamazepine- but not Phenytoin-induced Severe Cutaneous Adverse Drug Reactions are Associated with HLA-B*1502 in a Thai Population Napat Prabmeechai
Somsak Tiamkao
Thawinee Jantararoungtong
Pansu Chumworathayi
Piyameth Dilokthornsakul
Wichittra Tassaneeyakul
2010 Thai Journal of Pharmacology
(32 No 1), pp. 242-245
18. Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation Hasaya Dokduang
Nisana Namwat
Apinya Jusakul
Vajarabhongsa Bhudisawadi
Watcharin Loilome
Puangrat Yongvanit
Banchob Sripa
Wichittra Tassaneeyakul
2010 Srinagarind Medical Journal
(25 No 1), pp. 2-5
19. Selective Inhibition of Human Cytochrome P450 1A2 by Moringa oleifera Theerada Taesotikul
Vichien Navinpipatana
Wichittra Tassaneeyakul
2010 Thai Journal of Pharmacology
(32 No 1), pp. 256-258
20. Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data Nitsupa Wattanachai
David J. Elliot
Verawan Uchaipichat
Wichittra Tassaneeyakul
John O. Miners
2010 Thai Journal of Pharmacology
(32 No 1), pp. 246-249
21. Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers Sirimas Kanjanawart
Sontaya Simasathiansopon
Prapawadee Paupairoj
Suda Vannaprasath
Siriporn Tiamkao
Dhanu Gaysonsiri
Panot Tangsucharit
Thanawat Kaewkamson
Wichittra Tassaneeyakul
2010 Thai Journal of Pharmacology
(32 No 1), pp. 253-255
22. Comparative in vitro Cytotoxicity of the Generic and Reference Products of Gemcitabine on Various Cancer Cell Lines Chariya Hahnvajanawong
Vajarabhongsa Bhudisawadi
Nisana Namwat
Banchob Sripa
Wichittra Tassaneeyakul
2011 Srinagarind Medical Journal
(26 No 1), pp. 2-8
23. Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions Thachanan Kongpan
Usanee Khunakornsiri
Prarinya Konyoung
Pansu Chumworathayi
Napat Pabmeechai
Sirimas Kanjanawart
Wichittra Tassaneeyakul
2013 Srinagarind Medical Journal
(28 No 1), pp. 120-130
24. Pharmacology and Factors Affecting the Therapeutic Efficacy of Clopidogrel Nontaya Nakkam
Sirimas Kanjanawart
Somsak Tiamkao
Wichittra Tassaneeyakul
2014 Srinagarind Medical Journal
(29 No 1), pp. 59-70
25. Incidence of Drug induced-Acute Generalized Exanthematous Pustulosis (AGEP) Reported in Udonthani Hospital Prarinya Konyoung
Wichittra Tassaneeyakul
2014 Srinagarind Medical Journal
(29 No 3), pp. 283-287
26. HLA-B*58:01 Genotype is Associated With Risk of Severe Cutaneous Reactions Induced by Allopurinol in Patients Admitted in Udonthani Hospital Usanee Khunakornsiri
Prarinya Konyoung
Thachanan Kongpan
Supanida Kwangsukstid
Sirimas Kanjanawart
Wichittra Tassaneeyakul
2014 Srinagarind Medical Journal
(29 No 2), pp. 127-132
27. Determination of Melatonin in Plasma by Liquid-liquid Extraction and High Performance Liquid Chromatography Coupled with Fluorescence Detection and Its Application for Melatonin Pharmacokinetic Study in Humans Nuttawut Jenjirattithigarn
Katcharin Phunikom
Thachanan Kongpan
Sirimas Kanjanawart
Jeffrey Roy Johns
Wichittra Tassaneeyakul
2014 Thai Journal of Pharmacology
(36 No 2), pp. 5-18
28. Pharmacology and Factors Affecting the Therapeutic Efficacy of Elopidogrel Nontaya Nakkam
Sirimas Kanjanawart
Somsak Tiamkao
Wichittra Tassaneeyakul
2014 ศรีนครินทร์เวชสาร (Srinagarind Medical Journal)
1 (29), pp. 59-70
29. Different Enzyme Cocktail Conditions Successfully Establish Primary Brain Tumor Cell Line Derived from Pilomyxoid Astrocytoma Patient Wiyada Punjaruk
Nitsa Pasasuk
Amnat Kitkhuandee
Paradee Auvichayapat
Wichittra Tassaneeyakul
2015 Srinagarind Medical Journal
(30 No 2), pp. 137-148
30. The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy Duanggamon Muengsaen
Suda Vannaprasaht
Wichittra Tassaneeyakul
Kritiya Butthongkomvong
Thipawan Bowornkitiwong
Luangyot Thongthieang
Parichart Pongthai
Kosin Wirasorn
Aumkhae Sookprasert
2016 Srinagarind Medical Journal
(31 No 5), pp. 105-108

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ
1. การวิเคราะห์ลักษณะของเซลล์มะเร็งท่อน้ำดี ที่ดื้อต่อยา gemcitabine และการทำให้เซลล์ที่ดื้อต่อยา gemcitabine กลับไปไวต่อยาโดยใช้ caged xanthones และ rhinacanthin-C ผศ.ดร. ศิริมาศ กาญจนวาศ
นางจริยา หาญวจนวงศ์
ศ.ดร. วิจิตรา ทัศนียกุล
รศ.ดร. นิษณา นามวาท
ผศ.ดร. วันชนะ สืบไวย
ผศ.ดร.นพ. สุวิน ว่องวัจนะ
ศ.ดร. วิชัย ริ้วตระกูล
โครงการย่อย ภายใต้ชุดโครงการวิจัย 2558 ทุนงบประมาณแผ่นดินประจำปี 2558

0.18500876426696777